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SUMMARY 
Ribbon synapses are tonically active, high-performance synapses found in the 
retina and inner ear. Morphologically, ribbon synapses are characterized by the 
presence of large electron-dense presynaptic specializations in the active zone, the 
synaptic ribbons. The synaptic ribbon is of particular importance for the physiology 
of ribbon synapses. But how the synaptic ribbon orchestrates ultra-fast synaptic 
transmission in ribbon synapses is still largely unknown. RIBEYE was identified by 
our group as a novel and major protein component of synaptic ribbons (Schmitz et al., 
2000). RIBEYE consists of a unique aminoterminal A-domain and a carboxy terminal 
B-domain which is identical to the protein CtBP2. RIBEYE(B)-domain consists of a 
NADH binding subdomain (NBD) and substrate-binding subdomain (SBD). SBD and 
NBD are connected by two flexible hinge regions, hinge 1 and hinge 2. From the 
identification and characterization of novel interaction partners of RIBEYE, we 
expect a better understanding of RIBEYE functions at ribbon synapse.  
In my theis work, I identified GCAP2 as a RIBEYE-interacting protein at 
photoreceptor ribbon synapses using various independent approaches. The guanylate 
cyclase activating protein 2 (GCAP2) is a recoverin-like neuronal Ca2+-sensor protein 
highly expressed in photoreceptors. Three members of the GCAP family (GCAP1, 2 
and 3) are known in the mammalian retina. GCAP2 contains four EF-hands from 
which the first EF-hand is non-functional and an aminoterminal myristoylation signal. 
GCAP2 is well known to modulate the activity of photoreceptor guanylate cyclases in 
a Ca2+-dependent manner in photoreceptor outer segments. But GCAPs are not 
restricted to outer and inner segments but are also present in the presynaptic terminals 
of photoreceptors. In immunolabelling analyses of the  bovine retina with GCAP2 
antibodies, I showed the presence of GCAP2 in the presynaptic terminals at the 
ribbon sites as well as close to the synaptic ribbon. The significance of GCAP2 in the 
presynaptic terminals was initially unknown. 
The GCAP2 prey clone that I obtained by the YTH screening with 
RIBEYE(B) as bait coded for the two carboxyterminal EF-hands (EF-hands 3 and 4) 
and the carboxyterminal region (CTR) of GCAP2. In the YTH system, I showed that 
the C-terminal region of GCAP2 is responsible for the interaction with hinge 2 region 
of RIBEYE. I corroborated the GCAP2-RIBEYE interaction using various 
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independent approaches. In bacterial GST pull-down assays, GCAP2 directly 
interacts with RIBEYE(B)-domain. In order to prove the GCAP2-RIBEYE 
interaction in vivo, I co-immunoprecipitated RIBEYE and GCAP2 from the bovine 
retina. Since RIBEYE is exclusively present at the synaptic ribbons in the mature 
retina, the co-immunoprecipitation experiments suggested that GCAP2 may be a 
component of synaptic ribbons. This hypothesis is further supported by biochemical 
assays,  high resolution confocal microscopy and Proximity-Ligation Assays. 
 The hypothesis that hinge 2 region of RIBEYE(B) represents the core 
docking region for GCAP2 is further supported by point mutants of the hinge 2 region 
that completely abolished RIBEYE-GCAP2 interaction. Binding of NAD(H) to 
RIBEYE promotes RIBEYE/GCAP2 interaction. We suggest that binding of GCAP2 
to the hinge 2 region requires the NAD(H)-induced, closed conformation of 
RIBEYE(B). The formation of the NAD(H)-induced closed conformation requires 
considerable structural rearrangements in the SBD and movement of both SBDa and 
SBDb. Based on the analyses of RIBEYE mutants we propose that an enhanced 
structural flexibility of the SBD in RE(B)C899S favors a conformation of the flexible 
hinge 2 region that is able to bind GCAP2 similar to the NAD(H)-bound 
conformation. Further investigations will be necessary to understand the complex 
regulation of GCAP2-RIBEYE interaction and how it is mediated by structural 
changes in the protein. 
Synaptic ribbons are known to disassemble via spherical disassembly 
intermediates in response to illumination in the mouse retina when intracellular Ca2+ 
is low. Interestingly, photoreceptor terminals that were infected with GCAP2-EGFP 
virus typically displayed a loss of synaptic ribbons as analyzed by co-immunolabeling 
with anti-RIBEYE and at the electron microscopic level. GCAP2 overexpression in 
the synapse works similar on ribbon dynamics as chelating Ca2+ inducing a reduction 
in the number of synaptic ribbons. Therefore GCAP2 was ideal candidate to mediate 
these Ca2+- dependent changes of synaptic ribbons. 
Interesting, GCAP2 knockout mice have a disturbance in synaptic 
transmission as measured by reduced b-waves in ERG analyses. The above results 
will help to understand i) which synaptic mechanisms are targeted by RIBEYE-
GCAP2 interaction, ii)  what are the GCAP2 effector proteins, iii) how the GCAP2- 
effector interaction is affected by intracellular Ca2+ concentrations iv)  how the 
recruitment of NADH to RIBEYE is regulated. 
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ZUSAMMENFASSUNG 
 
Ribbonsynapsen sind tonisch aktive Hochleistungssynapsen in der Retina und 
im Innenohr. Morphologisch sind Ribbonsynapsen durch die Anwesenheit von 
großen elektronendichten Strukturspezialisierungen in der aktiven Zone, den 
sogenannten Synaptic Ribbons, gekennzeichnet. Der Synaptic Ribbon ist von 
besonderer Bedeutung für die Physiologie der Ribbonsynapse. Aber wie genau der 
Synaptic Ribbon auf molekularer Ebene arbeitet, ist noch unbekannt. Das Protein 
RIBEYE wurde von unserer Gruppe als ein Hauptprotein der Synaptic Ribbons 
identifiziert (Schmitz et al., 2000). RIBEYE besteht aus einer aminoterminalen A-
Domäne und einer carboxyterminalen B-Domäne, die identisch mit dem Protein 
CtBP2 ist. Die B-Domäne lässt sich wiederum weiter untergliedern in eine NAD(H)-
bindende Subdomäne (NBD) sowie in die Substratbindungsdomäne (SBD). NBD und 
SBD sind durch zwei flexible Scharnierregionen, Scharnier 1 und Scharnier 2, 
miteinander verbunden. Von der Identifizierung und Charakterisierung von neuen 
Interaktionspartnern von RIBEYE erwarten wir ein besseres Verständnis vom Aufbau 
und der Rolle der Synaptic Ribbons in der Ribbonsynapse. 
In meiner Dissertationsarbeit, identifizierte ich das Protein Guanylatcyclase-
aktivierende Protein 2 (GCAP2) als ein RIBEYE-interagierendes Protein in der 
Photorezeptorsynapse. GCAP2 ist ein Recoverin-verwandtes Ca2+-Sensorprotein, das 
in Photorezeptoren stark exprimiert wird. Drei Proteine aus der GCAP Familie sind 
bei Säugern bekannt (GCAP1, 2 und 3). GCAP2 enthält 4 EF-Hände, von denen die 
erste nicht-funktionell ist GCAPs enthalten ein aminoterminales 
Myristoylierungssignal. Von GCAP2 ist bekannt, dass es in den Außensegmenten der 
Photorezeptoren auf eine Ca2+-abhängige Weise die Aktivität membranständiger 
Guanylatcyclasen reguliert. GCAPs sind aber nicht nur auf das Außensegment 
beschränkt, sondern finden sich auch in der präsynaptischen Terminale von 
Photorezeptoren. In Immunfluoreszenzanalysen zeigte ich die Anwesenheit von 
GCAP2. Dort ko-lokalisiert GCAP2 mit RIBEYE und findet sich auch in der 
unmittelbaren Nachbarschaft von Synaptic Ribbons. Die funktionelle Bedeutung von 
GCAP2 in den präsynaptischen Terminalen war vor Beginn meiner 
Dissertationsarbeit noch komplett unbekannt.  
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In einem Hefe-Zwei-Hybridscreen (YTH) „fischte“ ich unter Verwendung von 
RIBEYE(B) als Köderprotein GCAP2 als potentiellen Interaktionspartner von 
RIBEYE. Der  GCAP2 Beuteklon kodierte dabei für die beiden carboxyterminalen 
EF-Hände sowie den Carboxyterminus von GCAP2 (CTR). Im YTH System zeigte 
ich, dass die CTR Region von GCAP2 mit der Scharnierregion 2 von RIBEYE(B) 
interagiert. Diese Hefebefunde wurden mit verschiedenen anderen unabhängigen 
Untersuchungsmethoden weiter abgesichert und bestätigt. Unter Verwendung von 
bakteriell exprimierten und gereinigten Fusionsproteinen konnte ich zeigen, dass 
RIBEYE(B) und GCAP2 auch in-vitro interagieren. Um die Bedeutung dieser 
Interaktion auch in-situ zu zeigen,stellte ich Co-Immunopräzipitationsuntersuchungen 
an. Ich konnte RIBEYE mit GCAP2 ko-präzpitieren (und umgekehrt), was für die 
physiologische Relevanz der gefundenen Interaktion spricht. Da RIBEYE in der 
Retina praktisch aüsschließlich an den Synaptic Ribbons vorhanden ist, sind diese 
Ko-Immunpräzipitationsdaten ein starker Hinweis darauf, dass GCAP2 eine 
Komponente der Synaptic Ribbons darstellt. Diese Hypothese wird weiter durch 
biochemische assays, hochauflösende konfokale Laserscanning-Untersuchungen 
sowie durch Proximity-Ligation-Assays unterstützt. 
Die Scharnierregion 2 stellt die Hauptbindungsstelle für GCAP2 dar, was ich 
durch die Analyse entsprechender Punktmutanten weiter bestätigen konnte, die die 
Interaktion mit GCAP2 komplett unterbanden. Aufgrund Struktur-Funktions-
Untersuchungen schlage ich vor, dass die Bindung von GCAP2 an die hochflexible 
Scharnierregion eine geschlossene Konformation der B-Domäne von RIBEYE 
benötigt. Die Bildung der NAD(H)-induzierten geschlossenen Konformation von 
RIBEYE erfordert umfassende Umstrukturierungen auch in der SBD sowie eine 
Rotation der SBD relativ zur NBD. Basierend auf der Analyse von RIBEYE 
Punktmutanten schlage ich vor, dass die erleichterte strukturelle Flexibilität einzelner 
RIBEYE-Punktmutanten (z.B. RIBEYEC667S und RIBEYE(C899S) eine 
Konformation der Scharnieregion 2 erleichtert, die für die Bindung von GCAP2 
benötigt wird. Weitere zukünftige Untersuchungen sind notwedig, um zu verstehen, 
wie diese Interaktion in-situ reguliert wird.  
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Synaptic Ribbons sind keine statischen Strukturen, sondern können sich in 
Abhängigkeit externer und interner Faktoren vergrößern oder verkleinern. Synaptic 
Ribbons können sich als Antwort auf verringertes intrazelluläres Ca2+ über 
sphärische Zwischenstufen (synaptic spheres) verkleinern. Interessanterweise konnten 
wir zeigen, dass die Infektion von Photorezeptoren mit GCAP2 ebenfalls zu einer 
Reduktion der Zahl der Synaptic Ribbons führen, so dass GCAP2 ein wichtiger 
Mediator dieser Ca2+-abhängigen Plastizität der Synaptic Ribbons sein könnte. 
Interessanterweise zeigen GCAP2 Knockout-Mäuse eine Störung in der 
synaptischen Transmission, die sich im ERG in einer Reduktion der b-Welle äussert. 
Diese Störung der synaptischen Transmission in den GCAP2 Knockout-Mäusen 
könnte auf eine gestörte Funktion der Synaptic Ribbons zurück zu führen sein. Die 
oben beschriebenen Daten werden helfen, weitere wichtige Fragestellungen zu 
beantworten: 1.) welche synaptische Prozesse werden durch die RIBEYE/GCAP2 
Interaktion targetiert; 2.) was sind die GCAP2-Effektorproteine in der Synapse; 3.) 
Welche Rolle spielt Ca2+ bei der  RIBEYE/GCAP2 Interaktion; 4.) wie wird in-situ 
die Bindung von GCAP2 an RIBEYE vermittelt?  
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Vision is a highly complex task that involves several steps of parallel 
information processing in various areas of the central nervous system. The eye, a 
remarkable photo-sensor, can detect a single photon and transmit its signal to the 
higher brain center. Complex processing in the different classes of retinal neurons 
(photoreceptors, bipolar cells, horizontal cells, amacrine cells and ganglion cells) are 
the cellular substrates for visual signal processing. Conventional neurons encode 
information by changes in the rate of action potentials; this limits the amount of 
information transfer. However, sensory neurons such as photoreceptors in the retina 
and hair cells in the cochlea transmit light and sound signals, over a dynamic range of 
several orders of magnitude in intensity by graded changes in transmitter release. 
Graded synaptic output requires the release of several hundreds to several thousands 
of synaptic vesicles per second (for review, see Parsons and Sterling, 2003; Sterling 
and Matthews, 2005). To accomplish this high level of performance, the sensory 
neurons of the eye and cochlea maintain large pools of fast releasable synaptic 
vesicles and are equipped with a special type of chemical synapse, the ribbon synapse 
(for review, see Parsons and Sterling, 2003; Sterling and Matthews, 2005). 
 
1. 1. Structure and function of retina 
 The eye is a fluid-filled sphere enclosed by three layers of tissue. The outer 
layer is the sclera and this opaque layer is transformed into the cornea, a specialized 
transparent tissue that permits light rays to enter the eye. The middle layer of tissue 
includes three distinct but continuous structures: the iris, the ciliary body, and the 
choroid. The innermost layer of the eye, the retina, contains neurons that are sensitive 
to light and are capable of transmitting visual signals to higher brain centre via optic 
nerve. Despite its peripheral location, the retina or neural portion of the eye is actually 
part of the central nervous system (for review, see Purves et al., 2001). 
 Although it has the same types of functional elements and neurotransmitters found in 
other parts of the central nervous system, the retina comprises only a few classes of 
neurons, and these are arranged in a manner that has been less difficult to unravel 
than the circuits in other areas of the brain. There are five main types of neurons in 
the retina: photoreceptors, bipolar cells, ganglion cells, horizontal cells, and amacrine 
cells. The cell bodies and processes of these neurons are stacked in five alternating 
layers, with the cell bodies located in the inner nuclear, outer nuclear, and ganglion 
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cell layers, and the processes and synaptic contacts located in the inner plexiform and 
outer plexiform layers. A direct three-neuron chain  photoreceptor cell to bipolar cell 
to ganglion cell is the major route of information flow from photoreceptors to the 
optic nerve (for review, see Purves et al., 2001).    
 
                       
              
Figure  1. Ribbon synapses of the mammalian retina   
A. Toluidine blue-stained vertical cryostat section of a mammalian retina showing the various retinal layers (OS/IS 
outer and inner segments of the rod and cone photoreceptors, ONL outer nuclear layer containing the somata of the 
photoreceptors, OPL outer plexiform layer or first synaptic region, INL inner nuclear layer containing the somata 
of the second order neurons, i.e. horizontal, bipolar and amacrine cells, IPL inner plexiform layer or second 
synaptic region, GCL ganglion cell layer containing the somata of the ganglion cells and of displaced amacrine 
cells) (Tom Dieck et al., 2006). (B) Diagram of the basic circuitry of the retina (obtained from NCBI). A three-
neuron chain—photoreceptor, bipolar cell, and ganglion cell—provides the most direct route for transmitting 
visual information to the brain. Horizontal cells and amacrine cells mediate lateral interactions in the outer and 
inner plexiform layers, respectively.  
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There are two types of light-sensitive elements in the retina: rods and cones. Both 
types of photoreceptors have an outer segment that is composed of membranous disks 
that contain photo-pigment and lies adjacent to the pigment epithelial layer and an 
inner segment that connects to the soma with the cell nucleus. The cell body gives 
rise to synaptic terminals that contact bipolar and horizontal cells. Absorption of light 
by the photo-pigment in the outer segment of the photoreceptors initiates a cascade of 
events that changes the membrane potential of the receptor, and therefore the amount 
of neurotransmitter released by the photoreceptor synapses on to the cells they 
contact. The synapses between photoreceptor terminals and bipolar cells (and 
horizontal cells) occur in the outer plexiform layer. More specifically, the cell bodies 
of photoreceptors make up the outer nuclear layer, whereas the cell bodies of bipolar 
cells lie in the inner nuclear layer. The axonal processes of bipolar cells make 
synaptic contacts in turn on the dendritic processes of ganglion cells and amacrine 
cells in the inner plexiform layer. The much larger axons of the ganglion cells form 
the optic nerve and carry the information about retinal stimulation to  lateral 
geniculate nucleus of thalamus (for review, see Purves et al., 2001). The  other two 
types of neurons in the retina, horizontal cells and amacrine cells, have their cell 
bodies in the inner nuclear layer and are primarily responsible for lateral interactions 
within the retina. These lateral interactions between receptors, horizontal cells, and 
bipolar cells in the outer plexiform layer are mostly responsible for the visual 
system's sensitivity to luminance contrast over a wide range of light intensities (for 
review, see Purves et al., 2001). 
 
1.2. Ribbon synapse of retina 
   Ribbon synapses of the vertebrate retina are unique chemical synapses 
characterized by pre-synaptic specializations, the synaptic ribbons. Synaptic ribbons 
are sheet-like organelles with a lamellar organization (Dowling, 1987; Sterling,1998; 
Schmitz,2009). The photoreceptor ribbon is a plate like, ~ 30nm thick structure, 
which extends perpendicular to the plasma membrane. The ribbon juts ~200nm into 
the cytoplasm, varies in length from 200-1000nm Photoreceptor ribbons are usually 
longer than bipolar cells ribbons. The ribbon anchors along its base to an electron-
dense structure (arciform density) that in turn anchors to the pre-synaptic membrane.  
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Figure  2. Transmission electron micrograph of the photoreceptor ribbon synapse 
Abbreviations: sv, synaptic vesicle; bc, postsynaptic dendrites of bipolar cells; hc, postsynaptic dendrites of 
horizontal cells; black arrows-synaptic vesicle; bold arrow head- endocytosis; arrow head- postsynaptic density 
(Schmitz, 2009). 
 
Physiologically ribbon synapses are characterized by a high rate of tonic 
neurotransmitter release mediated by continuous synaptic vesicle exocytosis 
(Dowling, 1987; Sterling, 1998). It is generally thought that ribbon synapses are 
specialized for rapid supply of synaptic vesicles for release and that this is achieved 
by fast delivery of synaptic vesicles to the active zone on the ribbon, analogous to a 
conveyor belt (for review, see Sterling and Matthews, 2005; tom Dieck et al., 2006). 
The ribbon’s surface is studded with small particles (~5nm diameter) to which 
synaptic vesicles tether via fine filaments (~5nm thick and ~40nm long). Usually 
there are several filaments per vesicle (Usukura et al., 1987). Vesicles tethered along 
the base of the ribbon directly contact the presynaptic membrane and thus are 
considered ‘docked’. Detailed studies of the distribution of various presynaptic 
proteins in ribbon synapses demonstrated that they generally contain the same 
proteins as conventional synapses (for review, see Sterling and Matthews, 2005; 
Schmitz, 2009). Only minor differences were observed, such as the use of syntaxin 3 
instead of syntaxin 1 for fusion and of L-type Ca2+ channels instead of N-, P/Q-, or R-
type channels for Ca2+ influx. Furthermore, rabphilin and synapsins are absent from 
ribbon synapses in some but not all species (for review, see Sterling and Mathews, 
2005).  
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1.3. Synaptic vesicle cycle at ribbon synapses 
 Exocytosis at the bipolar ribbon synapse has been observed directly. The 
synaptic vesicles labelled by the dye FM1-43 are seen to pause at the membrane and 
then, upon opening of Ca2+ channels, all the dye released promptly within 
milliseconds.  This process can observed by total internal reflection microscopy 
(Zenisek et al., 2000). The de-staining is consistent with full fusion (Zenisek et al., 
2000).  The bipolar cell active zone can release neurotransmitter continuously for 
hundreds of milliseconds during strong stimulation. This release exhibits two 
kinetically distinct components: a small fast pool (20% of the total vesicle pool) is 
released in 1 ms, and a large sustained pool (80%) is released over several hundred 
milliseconds (for review, see Sterling and Matthews, 2005). The fast pool matches the 
number of vesicles docked at the base of the ribbon, and the sustained pool matches 
the number of vesicles tethered to the ribbon in higher rows, more distant from the 
plasma membrane (for review, see Sterling and Matthews , 2005). The neat 
correspondence between the pool of tethered vesicles and the pool for sustained 
release in both rods and bipolar cells suggests that the ribbon might serve as a 
platform where vesicles can be primed to allow sustained release (for review, see 
Sterling and Matthews , 2005) 
 The large amount of exocytosis during sustained vesicle exocytosis requires 
equally high-capacity endocytosis to retrieve the added membrane. In cone 
photoreceptors, fused membrane is directly recycled into small synaptic vesicles, 
without intermediate pooling into endosomes (Rea et al., 2004). The recycled vesicles 
are mobile and, diffusing as fast as similarly sized microspheres and rapidly replenish 
the releasable pool (Rea et al., 2004). Surprisingly, bipolar cells rely on a different 
mechanism for rapid retrieval, in which membrane is endocytosed in large bites that 
only later give rise to recycled synaptic vesicles (Paillart et al., 2003).  Unlike cones, 
where newly recycled vesicles rapidly appear in the pool tethered to ribbons, recycled 
vesicles make up only 10% of the vesicles on bipolar cell ribbons, even after 10 min 
of activity (Rea et al., 2004).Thus, the bipolar cell relies on its large reserve of 
synaptic vesicles to replenish the releasable pool, whereas cone photoreceptors 
evidently have no large reserve pool and rely instead on rapid recycling. In this 
regard, the cone ribbon synapse resembles the conventional amacrine cell synapse, 
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where extensive labelling of recycled synaptic vesicles was observed, without 
significant labelling in larger endosomes (Paillart et al., 2003).  
 
 
Figure  3. 3D representation of synaptic ribbons (Von Gersdorff et al., 2001). 
Vesicles (yellow color) are reserve, vesicles (blue color) bound to synaptic ribbons are considered as tethered, 
vesicles tethered along the base of synaptic ribbon (red vesicles) are considered as docked (Sterling et al., 2005). 
A typical bipolar contains 5-7 calcium channels in the preactive zone. 
 
1. 4. RIBEYE- a major component of synaptic ribbon 
1.4.1. The molecular structure of RIBEYE 
The major component of synaptic ribbons from retina was identified as 
RIBEYE (Schmitz et al., 2000). RIBEYE is composed of unique N-terminal A - 
domain specific for ribbons, mediates assembly of RIBEYE into large structures, and 
a B - domain identical with CtBP2, a transcriptional repressor that in turn is related to 
2-hydroxyacid dehydrogenases. RIBEYE(B)-domain binds to NADH/NAD with high 
affinity (Schmitz et al., 2000). The A-domain contains 563 aa residues and B-domain 
contains 425 aa residues. The A-domain is not significantly homologous to any of the 
currently described proteins and it contains abundance of serine and proline residues 
(Schmitz et al., 2000). The B-domain is identical to CtBP2, a nuclear protein and 
together with CtBP1 constitutes a family of transcriptional co - repressors except to  
the first 20 amino terminal amino acids. CtBP1 was originally identified as  “C 
terminal binding protein” for the adenovirus E1A protein (Schaeper et al, 1995), and 
CtBP2 was subsequently identified as close structural and functional homolog of 
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CtBP1(Katsanis et al., 1998). The RIBEYE(A)-domain is not present in D. 
melanogastor, C. elegens and other lower vertebrates and invertebrates. This is 
supporting the notion that RIBEYE are an evolutionary innovation of vertebrates 
(Schmitz et al., 2000).  
The teleosts fish, Fugu and zebra fish have two ribeye genes, ribeye a and 
RIBEYE(B). Depletion of RIBEYE in zebra fish (by the use of morpholino antisense 
oligonucleotides) has been shown to result in shorter synaptic ribbons (Wan et al., 
2005). Fish deficient in ribeye a lacks an optokinetic response. It has shorter synaptic 
ribbons in photoreceptors and fewer synaptic ribbons in bipolar cells (Wan et al., 
2005). 
 
Figure  4. Schematic domain structure of RIBEYE 
RIBEYE contains of a large amino-terminal A-domain and a carboxyterminal B-domain. The B-domain of 
RIBEYE contains the NADH-binding subdomain (NBD, depicted in yellow) and the substrate-binding subdomain 
(SBD, denoted in red).The A domain comprises of 563 aa and B domain comprises of 425 aa (adapted from 
Magupalli et al., 2008). 
 The design of RIBEYE as a fusion protein of a novel domain with a pre-
existing transcription factor suggests an intriguing evolutionary history, an accidental 
origin of RIBEYE in the vertebrate lineage by serependipitous addition of an exon 
encoding the A-domain to the pre-existing CtBP2 gene. However, further analyses 
indicate that the evolutionary history of RIBEYE may be even more complex and 
give a clue to the possible function of the B - domain (Schmitz et al., 2000). CtBP1 
and CtBP2 themselves are not novel in terms of sequence but are significantly 
homologous to enzymes of the family of NAD+-dependent 2-hydroxyacid 
dehydrogenases (Schmitz et al., 2000). In the nucleus the CtBP family protein plays a 
role in transcription repression and in the cytosol, they perform diverse functions 
associated with membrane trafficking, central nervous system synapses and in 
regulation of the microtubule cytoskeleton (for review, see Chinnadurai, 2003). 
Several studies indicated that RIBEYE is the major component of synaptic ribbons 
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(Schmitz et al., 2000; Zenisek et al., 2002; Wan et al., 2005; Magupalli et al., 2008; 
for review see Schmitz, 2009). Thus RIBEYE can be expected to exert a major 
influence on the function of synaptic ribbons. 
1.4.2. The structural model of RIBEYE(B) - domain 
The RIBEYE(B)-domain contains two globular subdomains, the NADH-
binding subdomain (NBD) and substrate-binding subdomain (SBD). The 
dinucleotide-binding domain with an evolutionarily conserved structure forms the 
core homology domain among these proteins (for review, see Chinnadurai, 2003). 
The NAD(H)-binding fold consists of two units of a mononucleotide-binding motif 
termed the Rossmann fold. The Rossmann fold is a conserved structural domain 
composed of three parallel β strands interconnected by α helices, forming a parallel 
twisted β sheet flanked by α helices with a βαβαβ topology. In the dehydrogenase 
domain, each repeated βαβαβ structural element binds a mononucleotide component 
of the NAD(H) coenzyme (for review, see Chinnadurai, 2003). Like other 
dehydrogenases, these structures demonstrate that CtBPs, CtBP1, CtBP2 and 
RIBEYE(B)-domain (Kumar et al., 2002; Nardini et al.,2003., Magupalli et al.,2008) 
homodimerize through the dinucleotide-binding domain, forming an extensive, 
largely hydrophobic dimerization interface (for review, see Chinnadurai, 2003; 
Magupalli et al., 2008). 
      
 Figure  5. Predicted RIBEYE(B) domain structure using homology modelling with CtBP1 
A,B) Structure model of the B-domain of RIBEYE based on the crystal structure of tCtBP1 (Kumar et al., 2002; 
Nardini et al., 2003; see also Magupalli et al., 2008; Alpadi et al., 2008). The structure model covers large parts of 
the B-domain (RE(B)575-905). The B-domain of RIBEYE consists of a NAD(H)-binding subdomain (NBD) and a 
substrate-binding subdomain (SBD) which are connected by two flexible hinge regions, hinge 1 and hinge 2 
(colored in blue). The dotted lines indicate the extensions of the hinge 1 and hinge 2 constructs tested in the YTH 
system. 
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1.4.2.1. Substrate - binding domain of RIBEYE(B) 
 In these structures, a deep cleft separates the SBD from the NBD, 
corresponding to a putative active site and the dinucleotide-binding pocket. For the 
D-2-hydroxyacid dehydrogenases, catalytic activity apparently proceeds through a 
“proton shuttle” between a histidine and a carboxylic acid residue (i.e., glutamate or 
aspartate) with the transfer of hydride ion between the substrate and coenzyme. An 
arginine residue located within proximity to the active site in 3PGDH interacts with 
the substrate carboxylic acid during catalysis. These residues are conserved in all D-
2-hydroxyacid dehydrogenases (for review, see Chinnadurai, 2003 & 2005). All 
mammalian CtBP orthologues as well the Drosophila CtBP homologue also include 
these residues (hCtBP1 residues H315, E295, R266; corresponding residues in 
BARS/CtBP1 include H304, E284, and R255) indicating CtBP might retain oxo-
reductase enzymatic activity (for review, see Chinnadurai, 2003 & 2005). 
Interestingly, most of the residues in the dehydrogenase consensus sequence are 
conserved in CtBPs and RIBEYE, including in particular the four residues that are 
involved in binding NAD+ (GXGXXG-18-D) and the three amino acids that function 
in catalysis (R-30-E-19-H) (Schmitz et al., 2000). This conservation suggests that 
RIBEYE and CtBPs may still be partly or completely enzymatically active (Schmitz 
et al., 2000; Kumar et al., 2002). 
 
1.4.2.2. NADH/NAD+ - binding domain of RIBEYE(B) 
   In addition to a central essential role in metabolism as a carrier of reducing 
equivalents, the nicotinamide adenine dinucleotide coenzymes (NAD and NADP) 
play a pivotal role in cellular signalling (for review, see Chinnadurai, 2003 & 2005). 
They also serve as substrates for covalent protein modifications as well as precursors 
to the synthesis of intracellular calcium mobilizing second messenger molecules i.e. 
cyclic - ADP ribose(cADPR) (for review, see Chinnadurai, 2003 & 2005).                  
RIBEYE(B) - domain binds to NADH and NAD+(Schmitz et al.,2000). Strong and 
specific binding of 14C-labeled NAD+ was also observed. Scatchard analysis 
uncovered a single class of binding site in RIBEYE/CtBP2 with an affinity of 1.3 µM 
NAD+. 14C-NAD+ binding was completely inhibited by a 100-fold excess of 
unlabeled NAD+ or by cibacron blue, which serves as a common ligand for NAD+ 
binding site in many proteins but was unaffected by serine (Schmitz et al.,2000).  
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Figure 6. Binding of NAD+ to the B Domain of RIBEYE/CtBP2 The Specificity of NAD+ binding to the B 
domain of RIBEYE. Binding of 10 µM 14C-labeled NAD+ in the absence of competitor (column 1, 100%) is 
displaced completely by 1 mM cold NAD+ (column 2) or 1 mM Cibacron blue 3GA, an NAD+ analog (column 3) 
but not by 1 mM serine (column 4).Column 5 shows binding to GST alone as background binding (Schmitz et al., 
2000).  
These results suggest that the homology of the RIBEYE(B) domain/CtBP2 to 
NAD+-dependent 2-hydroxyacid dehydrogenases is functionally important, and that 
the domain may serve as an enzyme in synaptic vesicle priming on synaptic ribbons 
and in transcriptional repression (Schmitz et al., 2000).  
 
1.4.3. The proposed functional role of RIBEYE in ribbon synapse 
 According to the model proposed by Schmitz et al., 2000,  the N-terminal A 
domain is involved in the formation of the synaptic ribbon. RIBEYE alone is not 
sufficient to organize bar shaped ribbons but requires at least one additional protein 
component indicated in the model as an inner-core protein. The presence of such a 
protein component is suggested by the finding of a second unique protein in the 
biochemically purified ribbon fraction, which has not yet been identified (Schmitz et 
al., 2000). Recently we have demonstrated that RIBEYE is a scaffolding protein with 
ideal properties to explain the assembly of synaptic ribbons as well as its ultra-
structural dynamics via the modular assembly mechanism (Magupalli et al., 2008). 
The RIBEYE(B) domain binds NAD+ with high affinity indicating that its 
homology with NAD+-dependent dehydrogenases is functionally relevant and it may 
in fact serve as an enzyme. It is interesting that the CtBP1, a close homolog of CtBP2, 
was recently also suggested to function in membrane traffic under the name of 
“BARS” (brefeldin A-ADP ribosylated substrate) (Weigert et al., 1999). CtBP1, as 
BARS, functioning as a  lysophophatidic acid coenzyme A acyltransferase in 
membrane fission in the Golgi complex (Weigert et al., 1999). The structural 
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similarity of CtBPs with NAD+-dependent dehydrogenases well known that CtBP is 
ADP ribosylated in an NAD+-dependent reaction in parallel with GAPDH (another 
NAD+-dependent dehydrogenase (Girolama et al., 1995). However, this assimilation 
also makes it difficult to judge how CtBP1 could function as a coenzyme A–
dependent acyltransferases, since there is few similarity between the mechanisms of 
acyltransferases and dehydrogenases,  raising questions about the precise enzymatic 
role of CtBP1 in Golgi membrane traffic (Schmitz et al., 2000). In large number of 
organisms CtBPs are transcriptional repressors and it shows that their NAD+ binding 
and enzymatic function may be enclose to perform this function (Schmitz et al., 
2000). PXDLS motif characterized as a consensus sequence which  is the binding 
sequences for CtBPs in their target proteins . By analogy, Schmitz et al., 2000 
suggested on the surface of the ribbons array of  B domain of RIBEYE (which is 
identical with CtBP2) is present. This RIBEYE is intend to interact with a target 
sequence containing the consensus motif PXDLS of CtBPs. This hypothesis shows 
that this interaction of synaptic vesicle protein which may contain target sequence and 
that may be involved in docking and/or translocation of vesicles and unnown 
enzymatic reaction of the B domain may be involved in priming. Identification of the 
binding partners for the B domain on the ribbon surface and the role of NAD+ binding 
in their function will give valuable insight into how this domain might perform this 
proposed function (Schmitz et al., 2000). In Recent shown that RIBEYE, the main 
component of synaptic ribbons, binds to Munc119, the mammalian ortholog of the C. 
elegans protein unc119 (Alpadi  et al., 2008). Munc119 in turn binds toCaBP4 which 
is an important regulator of L-type Ca2+ channels (Haeseleer and others 2004; 
Haeseleer 2008). Data provided further evidence for a molecular link between the 
synaptic ribbons and presynaptic Ca2+ channels.  Ca2+ - buffering systems in the 
presynaptic ribbon terminal have been recently reviewed (Thoreson 2007; Zanazzi 
and Matthews 2009). 
 
1.5. GCAP2 - a photoreceptor enriched protein 
The guanylate cyclase activating protein 2 (GCAP2) is a recoverin-like 
neuronal Ca2+-sensor protein highly expressed in photoreceptors (for review, see 
Koch et al., 2002; Palczewski et al., 2004). Three members of the GCAP family 
(GCAP1, 2 and 3) are known in the mammalian retina: GCAP 1 and 2 are expressed 
both in rod and cone photoreceptors whereas GCAP3 is exclusively found in cone 
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photoreceptors (Imanishi et al., 2002). GCAP2 contains four EF-hands from which 
the first EF-hand is non-functional. GCAP2 contains an aminoterminal myristoylation 
signal and is myristoylated in-situ (Olshevskaya et al., 1997). GCAP2 is well known 
to modulate the activity of photoreceptor guanylate cyclases in a Ca2+-dependent 
manner (for review, see Koch et al., 2002). GCAPs are not restricted to outer and 
inner segments of photoreceptors but are also present in the presynaptic terminals 
(Otto-Bruc et al., 1997; Duda et al., 2002, Pennesi et al., 2003; Makino et al., 2008). 
The significance of GCAP2 in the presynaptic terminals is unknown. 
 
 
Figure 7. The schematic drawing of GCAP2(aa1-204). The 4 EF- hands of GCAP2 are indicated in color. EF-
hand 1 (colored in yellow) is non-functional and does not bind Ca2+; EF-hands 2-4 (colored in green) are 
functional and bind Ca2+. Glycine G2 is myristoylated in-situ. 
1.6. Mechanisms of GCAP 
The mechanism of modulation of retinal Guanylate cyclases (RetGCs) by 
GCAPs is now better understood, less is known about the significance of multiple 
RetGCs and GCAPs. In vitro, GCAPs display some preferences toward RetGCs. For 
example, GCAP1 stimulates RetGC1 more efficiently than RetGC2, while GCAP2 
and GCAP3 effectively stimulate both RetGC1 and RetGC2. RetGC1 and GCAP1 are 
important for cone and rod function in humans. Mutations in the RetGC1 gene have 
been linked to Leber's congenital amaurosis type I (Perrault et al., 1996) and to 
autosomal dominant cone rod dystrophy (adCORD)(Kelsell et al., 1998) and defects 
in the GCAP1 gene have been linked to adCORD (Downes et al., 2001). A naturally 
occurring null mutation in RetGC1 in chickens, which have cone dominated retinas, 
leads to the loss of cones and rods. However, disruption of RetGC1 expression in 
mice leads to the degeneration of cones primarily (Yang et., 1999) indicating that 
RetGC2 may substitute for the loss of RetGC1 in murine rods. It is not clear why 
photoreceptors express two GCAP proteins with very similar biochemical behavior. 
The ratio of GCAP1 to GCAP2 in bovine retinas has been estimated at between 3:1 
and 4:1 (OttoBruc et al., 1997) and the GC activity stimulation attributable to GCAP2 
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has been estimated at about 30%. Based on this data, the question was raised of 
whether GCAP2 would have a physiological role in phototransduction (OttoBruc et 
al., 1997).  The compartmentalization of GCAP2 differs from that of GCAP1 in rods 
and cones of retinas from higher species (OttoBruc A et al., 1997). GCAP1 appears to 
be more abundantly expressed in the cone outer segments of human, monkey and 
bovine retinas. 
1.7. GCAP2 in visual cascade 
Visual excitation in retinal photoreceptor cells is mediated by a cascade that 
leads to the enzymatic hydrolysis of cGMP and the subsequent closure of cGMPgated 
channels in the plasma membrane. Recovery of the dark state requires the resynthesis 
of cGMP, which is catalyzed by particulate (membrane-associated) guanylate 
cyclases (RetGCs). RetGC activity has long been known to be stimulated with high 
cooperativity by the decrease in cytosolic [Ca2+] that follows light exposure (Koch et 
al., 1998). This cyclase stimulation has been proposed to be the major mechanism by 
which photoreceptors adjust their sensitivity according to background illumination 
(Koutalos et al., 1996). The soluble regulators that confer Ca2+sensitivity to RetGCs 
have been cloned and identified as 23kDa Ca2+binding proteins from the calmodulin 
superfamily (Koutalos et al., 1995) the guanylate cyclase-activating proteins 
(GCAPs).Two isoforms of RetGCs are expressed in mammalian retinas, RetGC1 and 
RetGC2 (Shyjan et al., 1992). RetGC1 localizes to the outer segments and synaptic 
terminals of rods and cones, (Liu et al., 1994) whereas the distribution of RetGC2 
within photoreceptors is less well known. Three isoforms of mammalian GCAPs, 
namely GCAP1, GCAP2 and GCAP3 have been isolated (Haeseleer et al., 
1999)GCAP1 and GCAP2 have both been localized to photoreceptors in numerous 
studies, (Howes et al., 1998) although reports of the distribution of GCAPs between 
rods and cones in different species have been more ambiguous (Howes et al., 1998). 
In the human, monkey and bovine species, GCAP1 immunoreactivity appears 
stronger in the cone outer segments, whereas GCAP2 immunostaining is seen in the 
entire region of rods and cones (Kachi et al., 1999). GCAP3 expression seems to be 
limited to humans (Haeseleer et al., 1999)  and zebrafish (Imanishi et al., 2002) 
localizing to all cone types in human retinas (Imanishi et al., 2002).  Whether 
individual GCAPs might play distinct roles in phototransduction is not known.  
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In photoreceptor cells, photoactivation of rhodopsin or cone visual pigment 
results in a transient decrease in the concentrations of Ca2+ and cGMP. These 
receptors and second messengers are linked through a cascade of specific activation/ 
inactivation reactions in phototransduction  The levels of Ca2+ and cGMP are strictly 
controlled and interconnected. cGMP is a gating ligand of the plasma membrane 
cation channels that are permeable to Ca2+ ions. After cGMP is hydrolyzed, the efflux 
of Ca2+ exceeds the influx, resulting in decreased [Ca2+] within the cell. The lowering 
of [Ca2+] triggers production of cGMP through activation of a photoreceptor-specific 
particulate guanylate cyclase (GC).                                     
                            
Figure 8. Domain structure of Guanylate Cyclase and their interaction with GCAP proteins (image 
from homepage of Prof.Dr. KW Koch; University of Oldenburg) 
The Ca2+ sensitivity of GC (e.g., the higher activity at low levels of [Ca2+]) is 
mediated by guanylate cyclase-activating proteins (GCAPs). When Ca2+ is low, 
GCAP proteins  activate GC activity, when Ca2+ is high GCAP proteins inactivate GC 
activity. Light sensitivity of vertebrate photoreceptor cells is controlled by multiple 
feedback loops that Ca2+ independent mechanisms (Dizhoor et al., 1996). 
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1.8.Working hypothesis 
In the biological system most of the protein, function with other proteins to 
build a functional cellular task depending upon certain external stimuli and stage of 
the cell. Synaptic vesicle cycles are orchestrated by protein-protein interactions in 
every step of exocytosis and endocytosis. In order to better understand the function of 
synaptic ribbons at a molecular level I performed a YTH screen using RIBEYE(B) as 
a bait and obtained the neuronal Ca2+- sensor protein GCAP2 as a potential prey. This 
interaction has been analyzed at the molecular and functional level in the following 
Ph.D. thesis work. 
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2.1. Bacterial strains  
Strain                          Genotype Source & Reference 
DH10B 
 
F- mcrA ∆(mrr-hsdRMS-mcrBC) 
φ80lacZ∆M15 ∆lacX74 recA1 endA1 
araD139 ∆ (ara, leu)7697 galU galK λ- 
rpsL nupG  
Invitrogen, 
Grant, S. et al. (1990)  
BL21(DE3) F- ompT hsdSB (rB-mB-) gal dcm (DE3) Invitrogen , 
Grodberg und Dunn, (1988)  
 
 
2.2. Yeast strains  
Strain                                 Genotype Source & 
Reference 
AH109 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, 
Gal4∆, gal80∆, LYS2::GAL1UAS-GAL1TATA-
HIS3,GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-
MEL1TATA-lacZ 
Clontech, 
James et al. 1996 
 
 Y187 MATα, ura3-52, his3-200, ade2-101, trp1-901, 
leu2-3, 112, gal4∆,. met, gal80∆, 
URA3:GAL1UAS-GAL1TATA-lacZ 
Clontech, 
Harper et al. 1993 
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2.3. Vectors 
                 
Vectors 
   
                                      Description 
 
  References 
 
 
 
 
 
pACT2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pGBKT7 
 
 
 
 
 
 
 
 
 
 
The pACT2 vector expresses a hybrid protein by a fusion 
of the GAL4-activation domain (AD), at high levels in 
yeast host cells from the constitutive ADH1 promoter 
(P); transcription is terminated at the ADH1 transcription 
termination signal. It also contains an HA epitope tag 
and a MCS. The protein is targeted to the yeast nucleus 
by the nuclear localization sequence from SV40 T-
antigen. It is a shuttle vector that replicates 
autonomously in both E. coli and S. cerevisiae and 
carries the bla gene, which confers ampicillin resistance 
in E. coli.  It also contains the LEU2 nutritional gene that 
allows yeast auxotrophs to grow on limiting synthetic 
media.  
 
The pGBKT7 vector expresses proteins fused to GAL4 
DNA binding domain (DNA-BD). In yeast, fusion 
proteins are expressed at high levels from the 
constitutive ADH1 promoter (PADH1); transcription is 
terminated by the T7 and ADH1 transcription 
termination signals (TT7 & ADH1). It also contains the 
T7 promoter and a c-Myc epitope tag, It is a shuttle 
vector replicates autonomously in both E. coli and S. 
cerevisiae from the pUC and 2 µ ori, respectively. It the 
Kan
r 
for selection in E. coli and the TRP1 nutritional 
marker for selection in yeast.  
 
 
  
 
 
 
Clontech 
Laboratories 
Inc. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clontech 
Laboratories 
Inc. 
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pSE1111 
 
 
 
 
 
pSE1112 
 
 
 
 
 
 
 
pGEX-KG 
 
 
 
 
 
 
 
 
 
 
pMAL-C2 
  
 
 
 
 
 
The pSE1111 vector expresses proteins fused to GAL4 
activation domain. It used as negative control vector 
(prey vector) for checking auto-activation of prey 
constructs. 
 
The pSE1112 vector expresses proteins fused to GAL4 
DNA binding domain. It used as negative control vector 
(bait vector) for checking auto-activation of bait 
constructs 
 
The pGEX-KG vector contains coding sequence for 
Glutathione S Transferase (GST), MCS, pBR322 origin, 
and ampicillin resistance, Ptac is transcription promoter 
for the expression of the GST or GST Fusions proteins, 
chemically inducible by IPTG, high-level expression. An 
internal lac Iq gene for use in any E. coli host. Very mild 
elution conditions for release of fusion proteins from the 
affinity matrix, thus minimizing effects on antigenicity 
and functional activity. PreScission™, thrombin, or 
Factor Xa protease recognition sites for cleaving the 
desired protein from the fusion product. 
 
 
The pMAL-C2 vector facilitates the expression and 
purification of foreign proteins/peptides in Escherichia 
coli by fusion to maltose-binding protein. It contains 
E.Coli male gene , Lac I and tac promoter. It has 
ampicillin resistance gene. 
 
 
 
Bai &Elledge,  
1996 
 
 
 
 
Bai & 
Elledge, 
1996 
 
 
 
Basal-vector 
from 
Pharmacia 
and pGEX-
KG gifted 
from 
T.C.Sudhof 
lab. 
 
 
 
Clontech 
laboratories 
Inc. 
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pSFV1 
 
The pSFV1 eukaryotic expression vector is a novel DNA 
expression system based on the Semliki Forest virus 
(SFV) Ashery et al.1999. It`s replicon has a broad host 
range and a high level of expression efficiency. It offers 
a proper glycosylation of the recombinant protein. The 
DNA of interest is cloned into the pSFV1 plasmid vector 
which serves as a template for in vitro synthesis of 
recombinant RNA. The recombinant RNA in the cells 
drives its own replication and capping, results in 
production of large amounts of heterologous protein in 
host cells while inhibiting host protein synthesis. The 
pSFV1 plamid has a ampicillin resistance gene 
 
 
 
Invitrogen life 
technology 
 
 
 
 
2.4. Oligonucleotides 
 
          Name 
         
 
Primer 
No 
 
              Sequence 
 
Restrication  
site 
 
GCAP2aa3-aa204 for 
 
657 
TTTTGGATCCTACAGCAGTTC
AGCTGGGAG 
 
BamHI 
 
GCAP2aa3-aa204rev 
 
633 
TTTTTCTCGAGTCAGAACATG
GCACTTTTCC 
 
XhoI 
GCAP2aa105-aa204for 677 
TTTTTGGATCCTAGGTGGCAG
CGACAAGGACCGCAATCGC BamHI 
GCAP2aa105-aa204rev 633 TTTTTCTCGAGTCAGAACATGGCACTTTTCC XhoI 
GCAP2aa118-aa204for 678 
TTTTTGGATCCTAGGTGGCAG
CCTGGACATCGTGGAGTCC BamHI 
GCAP2aa118-aa204rev 633 TTTTTCTCGAGTCAGAACATGGCACTTTTCC XhoI 
GCAP2aa158-aa204for 679 
TTTTTGGATCCTAGGTGGCAG
CGATGAAAATGGAGATGGTC
AG 
BamHI 
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GCAP2aa158-aa204rev 633 
TTTTTCTCGAGTCAGAACATGGC
ACTTTTCC 
 XhoI 
GCAP2aa171-aa204for 681 
TTTTTGGATCCTAGGTGGCAGCG
TTGAAGGT GCCCGTCGT 
BamHI 
GCAP2aa171-aa204rev 633 
TTTTTCTCGAGTCAGAACATGGC 
ACTTTTCC 
 XhoI 
RE(B)hinge1for 749 
TTTTCCATGGTAGGCGGTAGTGG
AATCGCCGTGTGAAC 
NcoI 
RE(B)hinge1rev 750 
TTTTGGATCCCCGCCGATACAGA
TTGAG 
BamHI 
RE(B)hinge2for 751 
TTTTCCATGGTAGGCGGTAGTGC
TCCAAATCTCATCTGGCA 
NcoI 
RE(B)hinge2rev 752 
TTTTGGATCCGCGACCTGTGATT
GCTCG 
BamHI 
RE(B)hinge2forT865S 822 
TGCACACCACACAGTGGCTGGT
ACAGC 
 
RE(B)hinge2revT865S 823 
GCTGTACCAGCCACTGTGTGGTG
TGCA 
 
RE(B)hinge2forW867E 826 
CCACACACAGCCGAATACAGCG
AACAAG 
 
RE(B)hinge2revW867E 827 
CTTGTTCGCTGTATTCGGCTGTG
TGTGG 
 
B-DOM for 
pACT2/pGBKT7 406 
TTTTCCATGGTTATCCGCCCCCA
GATCATGA 
NcoI 
B-DOM rev 
pACT2/pGBKT7 405 
TTTTCTCGAGCTATTGCTCGTTG
GGGTGCT 
XhoI 
NBD-RE(B) for 508 
TTTTGAATTCTTATCCCATCTGC
TGCAGT 
EcoRI 
NBD-RE(B) rev 509 
TTTTCTCGAGGCTGTACCAGGCT
GTGT 
 XhoI 
Moazed outward for 353 
GTTCCATGGAGATCCGCCCCCA
GATCAT 
NcoI 
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Moazed outward rev 354 GTTCTCGAGCTATTGCTCGTTGGGGT XhoI 
SBD-RE(B) for 523 
AACATCCCATCTGCTGCAGGAGGATCTT
ACAGCGAACAAGCATCA 
 
SBD-RE(B) rev 522 
TGATGCTTGTTCGCTGTTAGATCCTCCTG
CAGCAGATGGGATGTT 
 
RE(B) D758N for 866 TACTTACAGAACGGGATAGAGCGG  
RE(B) D758N rev 867 CCGCTCTATCCCGTTCTGTAAGTA  
RE(B) E844Q for 868 CATGAGTCTCAGCCCTTCAGCTTT  
RE(B) E844Q rev 869 AAAGCTGAAGGGCTGAGACTCG  
RE(B) F848W for 870 CCCTTCAGCTGGGCTCAGGGCCCA  
RE(B) F848W rev 871 TGGGCCCTGAGCCCAGCTGAAGGG  
RE(B)∆CTR for 406 
TTTTCCATGGTTATCCGCCCCCAGATCAT
GA 
NcoI 
RE(B)∆CTR rev 467 
TTTTCTCGAGCCAAGGAGTTGAAGTAAC
AA 
XhoI 
 
2.5. Plasmid Constructs 
GCAP2(95-204)pACT2. This YTH prey clone (encoding EF3, EF4 and CTR of 
GCAP2) was obtained by yeast two hybrid screening using RIBEYE(B) as bait 
(Alpadi et al., 2008). 
 
GCAP2(1-204)pACT2, encoding full-length GCAP2 cDNA. Full-length GCAP2 
was amplified by PCR with the following primers: forward primer (632): 
TTTTGGATCCTAATGGGGCAGCAGTTCAGC); reverse primer (633): 
TTTTTCTCGAGTCAGAACATGGCACTTTTCC) and retinal bovine cDNA as 
template. The PCR product was cloned into the BamHI/XhoI sites of pACT2. 
 
GCAP2(1-204)G2ApACT2, encoding full-length GCAP2 with a point-mutated 
myristoylation signal. The insert was amplified by PCR using following primers: 
point mutant-encoding forward primer (1072): 
TTTTGGATCCTAATGGCCCAGCAGTTCAGC, reverse primer (633): 
TTTTTCTCGAGTCAGAACATGGCAC TTTTCC and full-length GCAP2pGEX as 
template. The PCR product was digested with BamHI/XhoI and cloned into the 
respective sites of pACT2. 
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GCAP2(3-204)pACT2, encoding full-length GCAP2 from which the first two amino 
acids are deleted. The insert of GCAP2(3-204)pACT2 was amplified by PCR with the 
following primers: forward primer (657): TTTTGGATCCTACAGCAGTTCAGCT 
GGGAG); reverse primer (633): TTTTTCTCGAGTCAGAACATGGCACTTTTCC) 
and full-length GCAP2 cDNA as template. The PCR product was cloned into the 
BamHI/XhoI sites of pACT2. 
 
GCAP2(105-204)pACT2. The insert was amplified by PCR with the following 
primers: forward primer (677): TTTTTGGATCCTAGGTGGCAGCGACAAGGA 
CCGCAATCGC); reverse primer (633): TTTTTCTCGAGTCAGAACATGGC 
ACTTTTCC) and full-length GCAP2 cDNA as template. The PCR product was 
cloned into the BamHI/XhoI sites of pACT2. 
 
GCAP2(118-204)pACT2. The insert was amplified by PCR with the following 
primers: forward primer (678): TTTTTGGATCCTAGGTGGCAGCCTGGACATC 
GTGGAGTCC); reverse primer (633): TTTTTCTCGAGTCAGAACATGGCACT 
TTTCC) and full-length GCAP2 cDNA as template. The PCR product was cloned 
into the BamHI/XhoI sites of pACT2.  
 
GCAP2(158-204)pACT2. The GCAP2 (aa158-204) pACT2 was amplified by PCR 
with the following primers: forward primer (679): 
TTTTTGGATCCTAGGTGGCAGCGATGAAAATGGAGATGGTCAG); reverse 
primer (633): TTTTTCTCGAGTCAGAACATGGCACTTTTCC) and full-length 
GCAP2 cDNA as template . The PCR product was cloned into the BamHI/XhoI sites 
of pACT2. 
 
GCAP2(171-204)pACT2. The insert was amplified by PCR with the following 
primers: forward primer (681): TTTTTGGATCCTAGGTGGCAGCGTTGAAGGT 
GCCCGTCGT); reverse primer(633): TTTTTCTCGAGTCAGAACATGGC 
ACTTTTCC) and full-length GCAP2 cDNA as template. The PCR product was 
cloned into the BamHI/XhoI sites of pACT2. 
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GCAP2(1-204)pGEX. Full-length GCAP2 was excised from GCAP2(1-204)pACT2 
with NcoI/XhoI and cloned into the respective sites of pGEX-KG. 
 
GCAP2(171-204)E172DpACT2. The insert was generated by PCR with forward 
primer (1032): TTTTGGATCCTAGTTGATGGTGCCCGTCGT; reverse primer 
(633): TTTTTCTCGAGTCAGAACATGGCACTTTTCC using GCAP2(171-
204)pACT2  as template and cloned into the BamHI/XhoI sites of pACT2.  
 
GCAP1pMalC2. The insert was amplified by PCR using the following primers: 
forward primer (961): TTTTGAATTCATGGGGAACATTATGGACG): reverse 
primer (962): TTTTTCTAGATCAGCCGTCGGCCTCC and bovine retina cDNA 
library as template. The PCR product was cloned into the EcoRI/XbaI sites of    
pMal-C2. 
 
GCAP1(156-205)pACT2. The insert was amplified by PCR using following primers: 
forward primer (968): TTTTCCATGGAGATGGAGGGCGTCCAGAAG; reverse 
primer (969): TTTTCTCGAGTCAGCCGTCGGCCTCC and GCAP1pMalC2 as 
template. The PCR product was cloned into the NcoI/XhoI sites of pACT2. 
 
RE(B)pGBKT7 encoding full-length RIBEYE (B )domain 
The full length Ribeye(B) domain  was amplified by PCR with forward primer(406): 
TTTTCCATGGTTATCCGCCCCCAGATCATGA, reverse primer(405): 
TTTTCTCGAGCTATTGCTCGTTGGGGTGCT and bRIBEYE(B) cDNA as 
template. The PCR product was subsequently digested with NcoI/XhoI and cloned 
into the NcoI/salI sites of pGBKT7. 
 
RE(B)pMal-C2 encoding full-length RIBEYE B domain. The insert was generated 
via PCR with forward rimer(96):TTCACAATTGATCCGCCCCCAGATCATG, 
reverseprimer(979):TTCACTAGTCTATTGCTCGTTGGGGTGC and using 
rRE(B)pGEX(Schmitz et al,2000) as a template, digested with MunI/SpeI and 
subsequently cloned into the EcoRI/XbaI sites of pMAL-C2. 
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RE(B)hinge1pGBKT7; RE(B)663-691pGBKT7. The insert was generated via PCR 
with forward primer (749): TTTTCCATGGTAGGCGGTAGTGGAATCGCCGTGT 
GCAAC; reverse primer (750): TTTTGGATCCCCGCCGATACAGATTGAG using 
rRE(B) pMalC2 as template. The PCR product was cloned into the NcoI/BamHI sites 
of pGBKT7.  
 
RE(B)hinge2pGBKT7; RE(B)856-891pGBKT7. The insert was generated via PCR 
with forward primer (751): TTTTCCATGGTAGGCGGTAGTGCTCCAAATCT 
CATCTGCA; reverse primer (752): TTTTGGATCCGCGACCTGTGATTGCTCG 
using rRE(B) pMalC2 as template. The PCR product was cloned into the 
NcoI/BamHI sites of pGBKT7. 
 
RE(B)E844QpGEX,  
The insert was generated via PCR with outward forward primer (353): 
GTTCCATGGAGATCCGCCCCCAGATCAT, mutated forward primer (868): 
CATGAGTCTCAGCCCTTCAGCTTT; mutated reverse primer (869): 
AAAGCTGAAGGGCTGAGACTCATG,outward reverse primer (354) 
GTTCTCGAGCTATTGCTCGTTGGGGT using rRE(B)pSK as template. 
 
RE(B)E844QpGBKT7, was cloned by inserting the amplified mutated PCR product 
(see above) into the NcoI/SalI site of pGBKT7 (Alpadi et al., 2008). 
 
RE(B)F848WpGEX, 
The insert was generated  via PCR with outward forward primer (353): 
GTTCCATGGAGATCCGCCCCCAGATCAT; mutated forward primer (870): 
CCCTTCAGCTGGGCTCAGGGCCCA; mutated reverse primer (871): 
TGGGCCCTGAGCCCAGCTGAAGGG; outward reverse primer (354): 
GTTCTCGAGCTATTGCTCGTTGGGGT using RE(B)pGEX as template. 
 
RE(B)F848WpGBKT7, was cloned by inserting the amplified mutated PCR product 
(see above) into the NcoI/SalI site of pGBKT7 (Alpadi et al., 2008). 
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RE(B)D758NpGEX,  
The insert was generated  via PCR with outward forward primer (353): 
GTTCCATGGAGATCCGCCCCCAGATCAT; mutated forward primer (866): 
TACTTACAGAACGGGATAGAGCGG; mutated reverse primer (867): 
CCGCTCTATCCCGTTCTGTAAGTA; outward reverse primer (354): 
GTTCTCGAGCTATTGCTCGTTGGGGT using RE(B)pGEX as template. 
 
RE(B)D758NpGBKT7, was cloned by inserting the amplified mutated PCR product 
(see above) into the NcoI/SalI site of pGBKT7(Alpadi et al., 2008). 
 
RE(B)G730ApGBKT7.  
Full-length RE(B)G730A was excised from RE(B)G730A pGEX with NcoI/XhoI and 
cloned into the NcoI/SalI sites of pGBKT7 (Alpadi et al. 2008). 
 
RE(B)C683SpGEX. The point mutant was generated with the QuikChange  site-
directed mutagenesis kit (Stratagene) using using RE(B)pGEX (862) as template and 
the following primers: forward primer (816): CGACAGTCTCCCATATCCTC; 
reverse primer (817): GAGGATATGGGAGACTGTCG according to the 
manufacturers instructions.  
 
RE(B)C683SpMalC2. The insert was generated via PCR using following primers: 
forward (856): TTTTAGATCTATCCGCCCCCAGATCATG; reverse (857): 
TTTTGTCGACCTATTGCTCGTTGGGGTG and RE(B)C683SpGEX as template. 
The PCR product was cloned into the BglII/SalI sites of pMalC2 
 
RE(B)C899SpGEX. This construct was generated by a site-directed mutagenesis kit 
(QuikChange, Stratagene) using RE(B)pGEX (862) as template and the following 
primers: forward primer (810): TACGAAACTCTGTCAACAAAG; reverse primer 
(811): CTTTGTTGACAGAGTTTCGTA according  to the manufacturer’s 
instructions. 
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RE(B)C899SpMalC2. The insert was generated via PCR using following primers: 
forward (856): TTTTAGATCTATCCGCCCCCAGATCATG;  reverse (857): 
TTTTGTCGACCTATTGCTCGTTGGGGTG and RE(B)C899SpGEX as template. 
The PCR product was cloned into the BglII/SalI sites of pMalC2. 
 
RE(B)F904WpGBKT7 (Magupalli et al., 2008). 
 
RE(B)∆HDLpGBKT7. The insert was generated via overlapping PCR using the 
following primers PCR1: outward forward primer (353): 
GTTCCATGGAGATCCGCCCCCAGATCAT; reverse primer (504): 
GGATCCGAGCAGCTCCTCCTCCCAGATTGAGGATATGGCA. PCR2: forward 
primer (505): TGCCATATCCTCAATCTGGGAGGAGGAGCTGCTCGGATCC; 
outward reverse primer (354): GTTCTCGAGCTATTGCTCGTTGGGGT using 
ratRIBEYE in pSK (Schmitz et al., 2000) as template. The PCR product digested with 
NcoI/XhoI and cloned into the NcoI/SalI sites of pGBKT7. 
 
RE(B)∆CTRpGBKT7. In this RIBEYE(B) construct, the hydrophobic 
carboxyterminal region of RIBEYE(B) (aa912-988) is deleted. The insert was 
generated via PCR using the following primers: forward (406): 
TTTTCCATGGTTATCCGCCCCCAGATCATGA, reverse (467): 
TTTTCTCGAGCCAAGGAGTTGAAGTAACAA and RE(B)pGEX (864) as 
template. The PCR product was digested with NcoI/XhoI and cloned into the 
NcoI/SalI sites of pGBKT7.  
 
RE(B)NBDpGEX-KG encoding NAD (H)-binding domain of RIBEYE B domain 
(Magupalli et al., 2008). The NAD(H)-binding sub domain of RIBEYE(B) was 
amplified by PCR using rRIBEYE in pSK (Schmitz et al., 2000) as a template and the 
following primers Globular RE(B) FOR(508; 
TTTTGAATTCTTATCCCATCTGCTGCAGT), Globular RE(B) REV(509; 
TTTTCTCGAGGCTGTACCAGGCTGTGT); and cloned in frame with the GST-
encoding cDNA of pGEX-KG using the EcoRI and XhoI sites.  
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RE (B) NBDpGBKT7 (Magupalli et al., 2008). 
The NBD-cDNA was cut out from pRE (B) NBD-GEX by EcoRI, XhoI and cloned  
into pGBKT7 vector in frame with GAL4-BD of pGBKT7 at the EcoRI and SalI site. 
 
RE(B)SBDpGBKT7 encoding substrate binding domain of RIBEYE(B) domain 
The two parts of  substrate binding domain of Ribeye B domain was amplified by 
PCR using two sets of primers: outward forward 
(353):GTTCCATGGAGATCCGCCCCCAGATCAT; internal rev (522): 
TGATGCTTGTTCGCTGTTAGATCCTCCTGCAGCAGATGGGATGTT; Internal    
forward(523):AACATCCCATCTGCTGCAGGAGGATCTTACAGCGAACAAGCA
TCA outward reverse (354):GTTCTCGAGCTATTGCTCGTTGGGGT Then these 
two products were joined by Combo PCR using the outward forward (353) and  
outward reverse (354) primers and subsequently cloned into the NcoI/SalI sites of 
pGBKT7. 
 
RE(B)hinge2T865SpGBKT7. The insert was generated with the QuikChange site 
directed mutagenesis kit (Stratagene) according to the manufacturer’s instructions 
using the following primers: forward primer (822): 
TGCACACCACACAGTGGCTGGTACAGC; reverse primer (823): 
GCTGTACCAGCCACTGTGTGGTGTGCA using RE(B)856-891pGBKT7 as 
template. 
 
RE(B)hinge2W867EpGBKT7. This construct was generated with the QuikChange 
site directed mutagenesis kit (Stratagene) via PCR with forward primer (826): 
CCACACACAGCCGAATACAGCGAACAAG; reverse primer (827): 
CTTGTTCGCTGTATTCGGCTGTGTGTGG using RE(B)856-891pGBKT7 as 
template. 
 
RE(AB)pGBKT7 encoding full-length RIBEYE (A- and B- domain) (Magupalli et 
al., 2008). 
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2.6. Antibodies used for western blotting 
 
Antibody Source 
Dilution 
used Secondary antibody 
Dilution 
used 
GCAP2 6th immune 
serum 
Rabbit 
polyclonal 1:1,000 
Goat anti-rabbit (GAR)-
POX (SIGMA) 
Cat.No: A6154 1:10,000 
GCAP2(A1) (Santa Cruz)  
Cat.No: SC-59543 
Mouse 
monoclonal 1:1,000 
Goat anti-mouse 
(GAM) POX (SIGMA) 
Cat.No: A3673 1:10,000 
U2656 ( Schmitz et al., 
2000) 
Rabbit 
polyclonal 1:10,000 
GAR POX (SIGMA) 
Cat.No: A6154 1:10,000 
RIBEYE/CtBP2 (BD 
Transduction  
Laboratories) Cat.No: 
612044 
Mouse 
monoclonal 1:10,000 
GAM POX (SIGMA) 
Cat.No: A3673 1:10,000 
 
2.7. Antibodies used for Immunolabeling 
 
Antibody Source Dilution 
used 
Secondary antibody Dilution 
used 
GCAP2 6th immune 
serum 
Rabbit 
polyclonal 
1:500 GAR Cy3 (ZYMED) 
Cat.No: 81-6115 
 
1:1,000 
 
GCAP2(A1) (Santa Cruz)  
Cat.No: SC-59543 
 
Mouse 
monoclonal 
 
1:1,000 
GAM Cy3-(ROCK-
LAND) Cat.No: 610-
104-121 
 
1:1,000 
U2656 (Schmitz et al., 
2000) 
Rabbit 
polyclonal 
1:1000 GAR Cy2 
(ROCKLAND) 
Cat.No: 611-111-122 
 
1:1,000 
RIBEYE/CtBP2 (BD 
Transduction  
Laboratories) Cat.No: 
612044 
Mouse 
monoclonal 
1:500 GAM Cy2(Jackson 
ImmunoResearch) 
Cat.No:115-096-146  
 
1:1,000 
Gt1(K-20) (Santa Cruz) 
Cat.No: SC-389 
Rabbit 
polyclonal 
1:500 GAR Cy3 (ZYMED) 
Cat.No: 81-6115 
1:1,000 
Visual Arrestin (E-12) 
(Santa Cruz) Cat.No: SC-
3457 
Goat 
Polyclonal 
1:500 RAG Cy3 (SIGMA) 
Cat.No:: C 2821 
 
1:1,000 
SV2 A  (Synaptic 
Systems) Cat.No: 119 00 
2 
Rabbit poly- 
clonal 
1:500 GAR Cy2 
(ROCKLAND) 
Cat.No: 611-111-122 
1:1,000 
Synaptophysin (Sigma) 
Cat.No: S5768  
Mouse 
monoclonal 
1:500 GAM Cy2 (Jackson 
ImmunoResearch) 
Cat.No:115-096-146 
1:1,000 
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2.8. Enzyme, Proteins and molecular weight standards 
 
 Bovine serum albumin Sigma 
100 bp DNA-Leiter Roti® Mark Roth 
T4 DNA ligase Roche Diagnostics 
Low range protein standarRoti® Mark Roth 
 
Lysozyme Roth 
 
Restriction enzymes New England Biolabs 
Taq polymerase 
 
PeQLab 
 
 
 
2.9. Chemicals 
Agar-Agar Roth 
Agarose Roth 
3-Amino-1,2,4-triazol Sigma 
Ampicillin Roth 
BSA Sigma 
Chloroquine Sigma 
Coomassie Brilliant Blue R 250 Roth 
DEAE-Dextran Sigma 
N,N-Dimethylformamide Roth 
Disodium hydrogen phosphate Roth 
Dithiothreitol (DTT) Sigma 
EDTA Roth 
Ethidiumbromide Roth 
Glucose Roth 
Glutathione-Sepharose  Sigma 
Glycerol Roth 
Glycine Roth 
IPTG Roth 
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Potassium chloride Roth 
Potassium hydrogen phosphate Roth 
Lithiumacetate Sigma 
Magnesiumchloride Hexahydrate Roth 
β-Mercaptoethanol Roth 
Sodium azide Sigma 
Sodium carbonate Roth 
Sodium chloride Roth 
Sodium dihydrogenphosphate Roth 
NPG (n-Propylgallate) Sigma 
ONPG (o-Nitrophenyl-β-D-galactoside) Sigma 
Phenylmethylsulfonylfluoride (PMSF) Roth 
Ponceau-S Roth 
Saccharose Roth 
Sorbitol Roth 
Tris Roth 
Triton X-100 Fluka 
X-GaL(5-Brom-4-Chlor-3-indoyl-β-
galactoside) 
Roth 
 
 
2.10. Buffers & Media 
Acetate buffer (P3) 3 M Potassium acetate, 
pH  5.5 
3-Amino-1,2,4-triazol  10 mM in a dd H2O 
Ampicillin 50 mg/ml A.dest, steril 
filtered 
Bradford-Reagent 
Roti®-Quant 
Carl Roth, 
Breaking –buffer 100 mM Tris-HCl pH 8.0 
1 mM β-Mercaptoethanol 
20 % Glycerol 
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100 x BSA 10 mg/ml 
(Restriction digestion) 
New England Bio labs 
Coomassie-Brilliant 
blue stain 
600 ml Isopropanol 
1560 ml dd H2O 
240 ml acetic acid 
0,6 g Coomassie 
Brilliant Blue R 250 
OPTIMEM/GlutaMax™ 
medium 
 
10% (v/v) tryptose 
phosphate broth,  
20 mM HEPES,  
2.5% FCS 
ECL-solution 1:1 obtained with ECL 1 & ECL2 
(ECL1) 5.0ml 1M Tris-HCl , pH: 8.5 
500µl luminol 
220µl PCA 
Made up to 50ml with dd H2O 
(ECL2) 5.0ml 1 M Tris-HCl , pH 8.5 
32µl Hydrogen peroxide (30%) 
Made up to 50.0 ml with dd H2O 
De-staining solution for 
coomassie stain gel 
100 ml acetic acid 
300 ml Ethanol 
Make up to 1 litre with dd H2O 
Loading buffer for 
Agarose gel 
10 µl 100 mM EDTA 
490 µl  dd H2O 500 µl Glycerol 
LiAc/TE/DTT 
20 ml 1 M Lithium 
acetate 
10 ml 200mM DTT 
20 ml TE (0.1M Tris-
HCL, 10mM EDTA) 
- made up to 200 ml 
with ddH2O 
- Filter sterilized 
IPTG                                                                     0.1 M in PBS 
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Lysis buffer for E. coli 
(P2) 
 
200 mM NaOH 
1% SDS 
LB Nutrient medium for Bacteria  Invitrogen GmbH, 
Karlsruhe 
Na2CO3 1 M in dd H2O. 
ONPG-Stock solution 4 mg/ml in Z-Puffer 
5x PBS  40 g NaCl 
1 g KCl 
7.2 g Na2HPO4 
1.2 g KH2PO4 
Make up to 1 litre with 
dd H2O 
PMSF-Stock solution 40mM in 100% 
Isopropanol 
Polyacrylamidgel 10% 
(minigel) 
1 ml ddH2O, 
1.27 ml 1 M Tris pH 8.8 
1.67 ml 30% 
Acrylamide 
50 µl 10% SDS 
1 ml 50% Glycerol 
3.3 µl TEMED 
25 µl 10% APS 
Ponceau S-stain 
30 g Trichloroaceticacid  
5 g Ponceau S 
Make up to 1 litre with 
dd H2O 
10x restriction enzyme 
buffer 
New England Bio Labs 
®Inc.; 
Frankfurt/Main 
Resuspensions buffer 
(P1) 
50 mM Tris-HCL, pH 8.0 
10 mM EDTA 
100 µg/ml RNase A 
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SD-Dropout-Medium 
(Minimalmedium) 
BD biosciences 
26.7 g/l 
-L SD Dropout-liquid 
medium 
-W SD Dropout-liquid 
medium 
-LW SD Dropout-liquid 
medium 
-ALWH SD Dropout- 
liquid medium 
+0.69 g -Leu-DO 
Supplement (BD) 
+0.74 g -TRP-DO 
Supplement (BD) 
+0.64 g-Leu-TRP-DO 
Supplement(BD) 
+0.6 g-Ala-Leu-Trp-
HIS-Supplement (BD) 
All medium was make 
up to 1 litre with dd 
H2O Adjusted pH 5.8  
SDS-PAGE-
Electrophoresis buffer 
3.03 g Tris 
14.4 g Glycine 
1.0 g SDS 
Make up to 1 litre with 
dd H2O 
SDS-loading buffer 4 x 1.6 g SDS 
4 ml β-Mercaptoethanol 
2 ml Glycerol 
2 ml 1M Tris pH 7.0 
4 mg Bromo phenol blue 
2 ml of dd H2O. 
Taq-Puffer Peqlab  
2 x TBS 28 ml 5 M NaCl 
3 ml 1 M KCl 
1 ml 1 M CaCl2 
0.5 ml MgCl2 
4.5 ml 200 mM Na2PO4, pH 7.4 
20 ml 1 M Tris-HCl, pH 7.9 
Make up to 500 ml of filter dd H2O. 
1xTAE-Puffer 40 mM Tris pH 7.8 
10 mM Sodium acetate,  
1 mM EDTA 
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Transfer Buffer 
(Western Blot) 
TRIS 15.125 g  
Glycine 72.05 g 
Methanol 1 litre 
Make up to 5 litres with dd H2O. 
X-Gal solution 20 mg/ml in N,N-
Dimethylformamid 
(DMF) 
X-Gal detection solution 340µl X-Gal solution 
54 µl β-Mercaptoethanol 
Make up to 20 ml with  Z-Puffer  
YPD-Medium Clontech 
50g YPD dissolved in 1 
litre of ddH2O. 
Autoclave 
Z-buffer 
 
Z-Buffer: 
60mM Na2HPO4 
40mM NaH2PO4 
10mM KCl 
1mM MgSO4 
50mM  -mercaptoethanol 
pH7.0 Do not autoclave 
 
2.11. Instruments 
Biofuge fresco Heraeus 
Biofuge primo R Heraeus 
Biofuge stratos Heraeus 
Chemidoc XRS System Bio-Rad 
Elektrophoretic 
apparatus –Agarosegel 
 
Bio-Rad 
Elektroporator ECM 
399 
BTX 
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Flourescence microscope 
Axiovert 200MCamera 
AxioCam MRm 
Carl – Zeiss 
Incubator 
Bacteria/Yeast 
Memmert 
Incubator cell culture  
Sterile cycle CO2 
Incubator 
Thermo 
Multifuge1 S-R Heraeus 
PCR-
Mastercyclergradient 
Eppendorf 
pH-Meter Inolab 
SDS-PAGE  electrophoresis 
apparatus 
Mini-Protean II 2D Cell 
Bio-Rad 
Power Supply EPS 301 Amersham Biosciences 
Shaker Incubator 
Innova 4230 
New Brunswick Scientific 
Rotator NeoLab 
Rotor for Ultracentrifuge, 
70Ti 
Beckmann 
Sterilbank, Lamin Air 
Modell 1,2 
Holten 
Thermomixer compact Eppendorf 
Ultracentrifuge Beckmann 
Vortex VWR International 
Microtome-cryostat, 
Cryo-Star HM560MV 
Microm Int. GmbH, 
Walldorf 
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SW40 rotor  Beckman 
Rotator centrifuge, 
JA20 
Beckman 
 
2.12. Polymerase chain reaction  
The following criteria were changed according to need. Primers were designed 
manually according to some basic principles. The Tm value of primer was kept 
around 50-55°C. Primer length was usually not more than 20-22 bases. The restriction 
sites were added to the primers along with overhang ends for efficient digestion of 
PCR products and cloning into the specific vectors. Primers were diluted in sterile 
ddH20 to get a 100µM concentration. 100-200 ng of DNA was used as a template.  
PCR master mix 
10x PCR buffer-5µl   
10mM dNTPs-1µl 
Template DNA-100ng 
100µM Forward primer-0.5µl 
100µM Reverse primer-0.5µl 
Taq Polymerase (5U/µl)-1µl 
Sterile water to make up to 50µl 
PCR cycling conditions 
Initial Denaturation- 95°C for 2 mins  
8 cycles 
Denaturation     -      95°C for 30 sec 
Annealing         -      55°C for 30 sec 
Extension         -      72°C (approximately 1 min for 1000bp) 
30 cycles 
Denaturation     -      95°C for 30 sec 
Annealing        -       65°C for 30 sec  
Extension        -       72°C (approximately 1 min for 1000bp) 
Final extension  -    72°C for 7 mins 
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2.13. Agarose gel electrophoresis 
        Agarose gel electrophoresis is used for separation, purification and identification 
of plasmid DNA and DNA fragments. The size of a DNA fragment was determined 
by comparison with standard DNA marker. A Rough estimation of the DNA 
concentration can be made by comparing the band intensity of the sample and a 
reference marker DNA band upon staining with ethidium bromide. Depending on the 
size of the DNA molecules, the agarose concentration chosen was between 0.8 % and 
1.2 % (w/v). DNA-samples were mixed with 10x DNA loading buffer and applied 
into the wells of the gel. In parallel, a marker was loaded. 1X TAE buffer was used 
for agarose solution and as electrophoresis buffer. The electrophoretic separation was 
done at 5Volts/cm. DNA fragments were visualized by UV-light and documented 
using BIO-RAD Gel Doc machine. 
2.14. Agarose gel extraction 
The DNA fragments were extracted from agarose gel using the QIA®quick 
gel extraction kit. The specific DNA band was cut out from the gel. 1 ml of QX1 
buffer and 5µl of QX1 suspension were added to the excised gel band. This mixture 
was kept at 55°C shakers for 30 mins. Then the mixture was centrifuged at 13,000 
rpm for 1 mins and the supernatant was removed and to the pellet 1 ml of QX1 buffer 
was added and mixed. The centrifugation step was repeated. To the pellet 1 ml PE 
wash buffer wasadded and mixed. The mixture was centrifuged at 13,000 rpm for 1 
min and the supernatant was removed. This step was repeated and the pellet was dried 
at room temp for 15 mins. Then 30 ml of pre-warmed 1mM Tris HCl pH8.4 was 
added and kept at 55°C in thermal shaker for 10 mins. This mixture was centrifuged 
at 13,000 rpm for 2 mins and the supernatant which contains DNA was taken and 
used for further experiment. 
 
2.15. RESTRICTION DIGESTION & LIGATION (CLONING) 
Restriction Digestion mixture 
Plasmid         10.0µl 
10X buffer  3.0µl 
10X BSA  3.0µl 
Enzyme I 0.5µl 
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Enzyme II 0.5µl  
Sterile dd H2O to make up 30µl 
The insert and vector were digested with appropriate enzymes for 2 to 3 hours at 
37°C. The digested products were fractionated by agarose gel electrophoresis. Then 
appropriate band excised from the gel and eluted using Qiagen gel extraction method. 
The concentration of eluted insert and vector DNA was measured. The insert to 
vector concentration used for ligation is 3:1 weight ratio.  
Ligation mixture 
Insert                         12µl (approx.400ng) 
Vector                          4µl (approx.100ng) 
10X ligase buffer              2µl 
T4 DNA ligase    1µl 
Sterile water to make up      20µl 
The ligation mixture was incubated at room temp for over night. The amounts of 
restriction enzyme and DNA, the buffer and ionic concentrations, and the temperature 
and duration of the reaction varies depending upon the specific application. Then 2 µl 
of ligation mixture was electroporated to E.Coli DH10B bacteria. The colonies were 
selected on respective antibiotic plates and plasmids were isolated from mini culture 
and the insert was checked by restriction digestion and confirmed by sequencing. 
 
2.16. Precipitation of ligation mixtures 
The DNA was purified from high salt concentrations for an efficient 
transformation into E. coli DH10B by electroporation. It is done with 3mM sodium 
acetate. (1 volume ligation mixture, 1/10 volume 3M sodium acetate (pH 5.0) and 10 
volumes of ice cold ethanol). The DNA pellet was washed once with 70 % ethanol 
and resuspended in a suitable volume of dd H2O. 
 
2.17. Determination of DNA concentration  
The DNA molecules in solution can absorb UV-light and this absorption can 
be measured by a spectrophotometer. The higher the concentration, the greater optical 
density at 260nm. The following relationship exists between the optical density (OD) 
and the DNA concentration:  
Double stranded DNA: 1 OD
260 
= 50µg/ml  
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2.18. BACTERIAL TRANSFORMATION 
2.18. 1. Preparation of electrocompetent bacterial cells 
All procedures were carried out in sterile and aseptic environment. Glycerol 
stock of E.coli cells was freshly streaked on LB plate and incubated overnight at 
37°C. Overnight 50 ml LB preculture was grown at 37°C, 160 rpm after single colony 
inoculation. 500 ml main culture (in 2 liters flask) was prepared with inoculation of 
20 ml overnight grown preculture. Cells were grown at 37°C, 160 rpm till an OD600nm 
0.9-1.0 was reached. Electro competent cells were kept on ice. The culture was 
transferred to a sterile falcon tubes and centrifuged at 3,500rpm, 15min at 4°C. The 
cell pellet was washed thrice in the ice-cold, sterile, double-distilled water and 
centrifuged at 3,500rpm, 15min at 4°C. The final washed pellet (~4ml) was 
resuspended in 5 ml sterile, ice-cold 10% glycerol (made in sterile water). Aliquot’s 
of (50µl) cell suspension was made in prechilled 1.5 ml eppendorff tube, and frozen 
in liquid nitrogen. Electro competent cells were stored at -80°C for long term storage. 
Using this method, we routinely got at least 6 – 8 × (108) transformants/ µg DNA. 
2.18.2. Transformation of electrocompetent bacteria E.coli DH10B 
The LB medium was kept at room temperature for 30 mins. The electroporation 
cuvette was kept in the ice for 10 mins. The electrocompetent bacteria were thawed on 
the ice for 1 mins. 2 µl of ligated DNA or plasmid DNA was added to the competence 
bacteria and this sample added to the pre chilled cuvette. Electric shock was given at 
1200 mV current for 5 msec. Immediately after that, 1 ml of antibiotic free LB medium 
was added and the sample was transferred to the test tube and incubated at 37°C for 1 
hr. After incubation, the sample was spreaded on suitable antibiotic selection plate and 
incubated for over night at 37°C. A single colony was innoculated in LB 
mediumcontaining specific antibiotic (ampicillin/kanamycine) and this culture was used 
for plasmid preparation. 
 
2.19. ISOLATION OF PLASMID DNA 
2.19.1. Mini preparation  
Plasmid DNA was isolated from bacterial cultures using alkaline lysis method. 
Single bacterial colony was allowed to grow overnight in 5 ml of LB medium with 
appropriate amount of specific antibiotic at 37°C. 1 ml of culture was stored at 4°C for 
maxi preparation. 4 ml cultures were centrifuged in a 15 ml falcon tube at 4,000 rpm for 
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10 mins at 4°C. The pellet was resuspended with 250 µl of buffer 1. This mixture was 
transferred to 1.5 ml of microfuge tube. 250 ul of buffer 2 was added to that and mixed  
After incubating at room temp for 5 mins, 350 ul of buffer 3 was added and incubated 
for 10 mins at room temperature. This sample was centrifuged at 13,000 rpm for 15 
mins at 4°C. 600 ul supernatant was removed and mixed with 800 ul of isopropanol. 
This sample was centrifuged at 13,000 rpm for 20 mins. The supernatant was removed 
and the pellet was washed with 1 ml of 70% ethanol, air dried and resuspended in 40 ul 
of 1mM Tris HCl. 
 
2.19.2. Maxi preparation  
           Bacterial culture (usually 100ml) were harvested by centrifugation at 4000 rpm 
for 20 mins at 4º C. The pellet was resuspended in 5 ml of buffer 1 by vortexing. Then, 
5 ml of buffer 2 was added to that and incubated for 10 mins at room temp. There after, 
8 ml of buffer 3 was added and mixed thoroughly. This sample was centrifuged at 8500 
rpm for 20 mins until no pellet appears. The supernatant was transferred to 50 ml 
Beckman centrifuge tube and 15 ml of isopropanol was added to that. After 
centrifugation at 13,000 rpm for 1 hr, supernatant was removed and the pellet was 
washed with 15 ml of 70% ethanol; air dried and resuspended in 1 ml of 1 mM Tris 
HCl pH (8.5). 
 
2.19.3. Purification of plasmid DNA for sequencing 
        100 µl of plasmid DNA was mixed with 500 µl of Qiagen binding buffer and 
added to the column after centrifuge at 13000 rpm for 1 min. 500 µl of PE wash 
buffer was added and centrifuged at 13000 rpm for 1 min. the supernatant removed 
and the above step repeated again. Finally, the column was centrifuged without any 
previous addition of buffer to remove the traces of alcohol. 50 µl of prewarmed 1mM 
Tris HCl was added to the column kept for incubation at room temp for 5 mins and 
centrifuged. The supernatant collected contain plasmid DNA. The OD value of DNA 
was measured by spectrophotometer. Roughly 2µg of DNA was sent for sequencing 
to MWG sequencing service centre. 
2.20. Yeast Two Hybrid methods 
          For Yeast-Two-Hybrid (YTH) analyses, the Gal4-based Matchmaker Yeast-
Two-hybrid System (Clontech) was used according to the manufacturer’s 
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instructions. For the YTH screening we used a bovine retinal YTH cDNA library 
from the retina (Tai et al., 1999). The cDNA of the resp. bait proteins were cloned in 
frame with the Gal4-DNA-binding domain of pGBKT7. The cDNA of the indicated 
prey proteins were cloned in frame with the Gal4-activation domain of pACT2 or 
pGADT7. The bait and prey plasmids confer tryptophan and leucine prototrophy to 
the respective. auxotrophic yeast strains.  
 
2.20.1.Yeast cell transformation 
2.20.1.1. Preparation of electro competent yeast 
  Preparation of electrocompetent yeasts and electroporation of yeasts were 
done as described by Helmuth et al., 2001. For identifying transformants, yeasts were 
plated on the respective selective plates to identify the resulting convertents to the 
respective prototrophy (drop out media Clontech/QBiogene). The yeast strain AH109 
and Y187 were streaked from the glycerol stock on YPD plate and incubated at 30°C 
till the colony appeared. Precultures were made by inoculating the single colony in 10 
ml of YPD medium by incubation overnight at 30°C. From this, all steps were carried 
out in ice. The cells were harvested by centrifugation at 2,000 rpm for 10 mins at 4°C.  
The cell pellet was washed twice with sterile cold distilled water. The cells were 
collected from washing each time by centrifugation at 2,000 rpm for 10 mins at 4º C. 
Then the cells were treated with 1M sorbitol followed by centrifugation at 2,000 rpm 
for 10 mins at 4°C. Then, the cells were incubated with 20 ml of incubation mixture 
containing 100 mM LiAc, 10mM   - mercaptoethanol and 1X TE buffer at 30°C for 
30 mins at 250 rpm. The cells were collected by centrifugation at 2,000 rpm for 5 
mins at 4°C. 1M sorbitol washing step was repeated once. The pellet was bathed in 
100-200 ul of 1M sorbitol and it was used for electroporation. 
 
2.20.1.2. Electroporation 
     Electrocompetent (120µl) yeast cells were mixed with 1 ul of plasmid DNA 
and electroporated at 1,800 V for 5 msec. 1 ml of YPD medium was added to the 
mixture and incubated at 30°C for 1 hr at 600 rpm. After incubation, 100 ul of sample 
was spreaded on selection plates (AH109 -W plate; Y187 –L plate) and incubated at 
30º C for 2-3 days. 
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2.20.2. Yeast mating 
               Yeast strains Y187 and AH109 were used that contain distinct auxotrophic 
marker genes: AH109 [MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, Gal4∆, 
gal80∆, LYS2::GAL1UAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, 
URA3::MEL1UAS-MEL1TATA-lacZ] (James et al., 1996); Y187 [MAT, ura3-52, 
his3-200, ade2-101, trp1-901,leu2-3,112, gal4∆,. met, gal80∆, URA3::GAL1UAS-
GAL1TATA-lacZ] (Harper et al., 1993). The bait (pGBKT7) and prey 
(pACT2/pGADT7) plasmids confer tryptophan and leucine prototrophy to the 
respective auxotrophic yeast strains. Bait plasmids were always electroporated into 
AH109 yeast, whereas all prey plasmids were transformed into Y187. For interaction 
analyses, AH109 yeasts containing the resp. bait plasmid were mated with Y187 
yeasts containing the resp. prey plasmid. For the mating, pSE1111 and pSE1112 (Bai 
et al., 1996) as well as the empty bait and prey vectors were used as negative controls. 
Single colony from -L and –W plate (respective prey and bait construct) were added 
to the 1 ml of YPD medium and mixed. This sample was incubated at 30°C for 6 
hours. After incubation, the samples were pelleted down by centrifugation at 3,000 
rpm for 5 mins at 4°C. The supernatant was discarded and keep the cell pellet in 100 
µl of remaining supernatants. 50 µl of cells were spreaded on selection plate –LW; 
and another 50 µl of cells were spreaded on selection plate –ALWH +100 µl of 
10mM ATZ. The plates were incubated at 30°C until colony appears. 
 
2.20.3. -GALACTOSIDASE ASSAY 
                Expression of -galactosidase (-gal) marker gene activity was 
qualitatively analyzed by filter assays (Stahl, et al., 1996). 
 
2.20.3.1. Colony lift filter assay 
               To rule out the false positive that grown on dropout medium (-ALWH), this 
test was performed to determine which of the positive colonies are also  LAC Z 
positive, by screening for blue colour colonies in ß- galactosidase assay. The 
whatman filter paper (#1) was laid onto the yeast colonies. The filter paper was 
removed using forceps and immersed in liquid nitrogen by the facing colony side up. 
The Petridish was prepared with 20 ml Z buffer containing 340 ul of 50 mg/ml X-gal. 
A replica of the yeast colonies were made with whatman filter. The filter paper with 
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the cracked yeasts placed on the Z buffer, by colony faced up with out air bubbles. 
The petridish was covered with a led and placed at room temperature. 
 
2.21. Site directed mutagenesis 
 Site-directed mutagenesis involves the introduction of mutations at the DNA 
level to alter the primary amino acid sequence of proteins. COMBO PCR methods for 
site-directed mutagenesis utilize four oligonucleotides primers in two rounds of PCR. 
In first round of PCR external forward and mutant reverse primers in one reaction (N- 
terminal PCR product); external reverse and mutant forward in another reaction (C- 
terminal PCR product). Pfu polymerase is used in this first round to prevent addition 
of ‘A’ which is done by Taq polymerase and which would result into a frame shift 
mutation.  In second round of PCR, there two PCR products are annealed 
afterdenaturation and amplified using external forward and external reverse primers. 
Taq polymerase was used in this second round PCR.  
PCR Master Mix-I 
10X Pfu buffer              -5µl 
10mM dNTPs              -1µl 
100µM Forward Primer                     -0.5µl 
100µM Reverse Primer             -0.5µl 
(Mutagenic) 
Template              -0.5µl 
Pfu Polymerase             -0.5µl 
Sterile dd H2O              -42µl 
PCR Master Mix-II 
10X Pfu buffer             - 5µl 
10mM dNTPs             - 1µl 
100µM Forward Primer 
 (Mutagenic)             - 0.5µl 
100µM Reverse Primer                    - 0.5µl 
Template             - 0.5µl 
Pfu Polymerase            - 0.5µl 
Sterile ddH2O             - 42µl 
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PCR cycling condition 
95°C -2 mins 
8 cycles 
95°C -30 secs; 55°C -30 secs ; 72°C  -1 min  
30 cycles 
95°C -30 secs ; 65°C -30 secs ; 72°C  -1 min  
1 cycle 
72° C -7 mins 
 
2nd round-COMBO PCR 
PCR Master Mix 
10X PCR buffer    -5µl 
10mM dNTPs    -1µl 
25mM MgCl2    -1µl 
100µM Forward Primer (353) -1µl 
100µM Reverse Primer (354)  -1µl 
Template (PCR-I)   -4µl 
Template (PCR-II)   -4µl 
Taq Polymerase   -1µl 
Sterile dd H2O              -35µl 
PCR CYCLING CONDITION (PEQLAB PCR MACHINE) 
95°C -5 mins 
1 cycle 
70°C -5 mins ; 65° C-5 mins ; 60°C -2 mins ; 72°C-3 mins 
30 cycles 
95°C-3 mins ;95°C -30 secs ; 65°C-30 secs ; 72°C-1:30 mins 
1 cycle 
72°C -10 mins 
 
2.22.PREPARATION OF RECOMBINANT PROTEIN  
2.22.1. Protein expression  
               The plasmid constructs, pGEX-KG, pGCAP2GEX-KG were electroporated 
into the electro-competent bacteria BL21 or DH10B and pMBP-C2, pRE (B) MBP-
C2 to BL21 at 1,200 volt for 5 ms. 1 ml of LB medium was added to these bacteria 
and incubated  for 1 hr at 37°C, 220 rpm. The bacterial cultures were spreaded on LB-
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Amp plates and incubated at 37°C overnight. The precultures were prepared by 
inoculating the overnight grown isolated colonies in 5 ml of LB medium with 10 ul of 
ampicillin and incubated for over night at 37°C at 220 rpm.The 5 ml of precultures 
were transferred to 500 ml of LB medium with 1 ml of ampicillin and incubation  was 
continued until an OD 600 of 0.8-0.9 at 37°C at 220 rpm. After reaching the 
appropriate OD, the cultures were incubated at room temperature for 30 mins. 600 ul 
of 100 mM IPTG was added to the growing culture for the induction of protein 
expression and incubation was continued for 5 hours at room temperature. From this 
step all experiments were done at 4°C. The cells were harvested by centrifugation at 
3,500 rpm for 20 mins. The pellet were washed thrice by resuspension with 50 ml of 
ice cold PBS and centrifuged at 3,500 rpm for 15 mins. Then, the pellets were 
incubated with 500µl of 10 mg/ml freshly prepared lysozyme in a total volume of 20 
ml of PBS for 1 hr at 4°C. The cell membrane was disrupted by sonication. The 
supernatants were collected by centrifugation at 13,000 rpm for 1 hr. This procedure 
was repeated until no pellet appears. 
 
2.22.2. Purification & elution of fusion proteins 
             1 ml of pre-swollen glutathione agarose beads or amylose beads (depending 
on the applied tag) were washed thrice with ice cold PBS and added to the 
supernatant containing the GST, GCAP2-GST protein and MBP, RE (B) - MBP 
respectively. These samples were incubated for over night at 4°C in cold room for 
binding of GST and GST fusion protein to glutathione agarose beads; MBP and MBP 
fusion protein to amylose beads. Then, the samples were centrifuged at 1,500 rpm at 
4°C for 2mins and the supernatant was removed. The pellets were washed thrice with 
50 ml of ice cold PBS for three times by shaking for 30 mins at 4°C. After last 
washing the beads were saved as bathed in 1000 µl of PBS. 20 µl of beads were 
loaded on to the 10 % SDS-PAGE for checking the expression. The MBP and MBP 
fusion protein was eluted using elution buffer containing 10mM TRIS-HCl pH (8.5), 
10% maltose in PBS in different fractions and checked it on 10% SDS-PAGE. The 
GST and GST fusion proteins were eluted in buffer containing 10mM reduced 
glutathione, 50mM TRIS-HCl pH (8.5). 
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2.22.3. Measurement of protein concentration 
 The Bradford assay was used to estimate the protein concentration 
(Bradford,1975). The absorbance for the protein-specific dye, Coomassie brilliant 
blue G-250, shifts from 465 nm to 595 nm when binding to protein occurs. The 
measured absorbance at 595 nm was blotted against a reference curve obtained with 
known concentrations of BSA. 
 
2.23. SDS-PAGE 
SDS PAGE was done by following Manniatis et al, 2005.   One dimensional 
gel electrophoresis under denaturing conditions in presence of 0.1 % SDS separates 
proteins according to their molecular size. The polyacrylamide gel is casted as a 
separating gel topped by a stacking gel. Sample proteins were solubilized by boiling 
in 6X SDS loading buffer. Coomassie Brilliant Blue R- 250 binds non-specifically 
toalmost all proteins, which allows detection of protein bands in polyacrylamide gels. 
Gels were stained with Coomassie staining solution with gentle shaking for 30 min at 
room temperature. The background was subsequently reduced by soaking the gel in 
acrylamide gel destaining solution. After that, gels were documented using either HP 
scanner or BIO RAD Gel Doc apparatus. 
 
2.24.Western blotting 
          Proteins were separated by SDS-PAGE and transferred from the 
polyacrylamide gel to a Nitrocellulose /Nylon membrane with a constant voltage (3 
hrs, 50 volt at 4˚c). After electroblotting, the membrane was stained with a Ponceau S 
for 2 mins. The Ponceau S stained membrane was documented using scanner. Then, 
the membrane was destained using PBS and blocked with 5% skim milk powder for 1 
hour. For immunodetection of proteins, the primary antibodies were diluted in 5% 
skim milk powder and the membrane was incubated for over night in cold room with 
constant mild shaking. Then the membrane washed three times with PBS. After that, 
the secondary antibody was diluted in 5% MMP and the membrane was incubated at 
room temp for 1 hour. Again the membrane washed with PBS 3 times. Then, the 
membrane was incubated with ECL1 and ECL2 mixture (1:1 ratio; 
chemiluminescence’s detection solution) and the signals were documented with BIO 
RAD Gel Doc apparatus. Also the band intensity was quantified using BIO RAD Gel 
Doc apparatus and the Gel Doc software. 
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2.25. GST pull down assay 
 GST and GST-GCAP2 bound to glutathione agarose beads were used as an 
immobilized partner (bait). The eluted MBP and RE (B)-MBP fusion protein were 
used as a prey for this assay. The eluted RE(B)-MBP fusion protein and MBP protein 
(control) were incubated with eluted GCAP2-GST fusion protein and GST protein 
(control) in equimolar concentration (0.8µM) in a total volume of 500 µl incubation 
buffer (100mM Tris-HCl (pH 8.0) ,150mM NaCl,1mM EDTA and 0.25% TritonX-
100). These samples were incubated for 4 to 6 hrs at 4°C. After incubation, the 
samples were centrifuged to remove the supernatant. The pellets were washed 5 times 
with incubation buffer every washing step was followed by centrifugation at 13,000 
rpm for 1 min at 4°C. The pellet was boiled in SDS-PAGE loading buffer at 96°C for 
5 mins. The eluted proteins were subjected to 10% SDS-PAGE followed by 
coomassie staining.  
 
Experiment set up 
Protein nature 
Concentration  
(mg/ml) 
Amount of protein 
used for each 
experiment (µg)  
GST Immobilized 2.1 10 
GCAP2-GST Immobilized 2.0 20 
MBP Eluted  1.4 20 
RE(B)-MBP Eluted  2.5 40 
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1 GST 0.24 15 
2 MBP                            0.7 15 
3 GCAP2-GST 0.5 15 
 Input            
4 RE(B)-MBP 0.8 15 
 
1 GST 2.4 100 MBP 7.1 100 
2 GCAP2-GST                                        5 100 RE(B)-MBP 8 100 
3 GST 2.4 100 MBP 7.1 100 
Pellet  
             
                 
4 GCAP2-GST 5 100 RE(B)-MBP 8 100 
 
5    
Unbound 
fraction 
RE(B)MBP 
40 8 
 
Input-protein used in the experiment 
Pellet – the portion which is settled after incubation followed by washing and 
centrifugation. 
 
2.26. BOVINE RETINA CO-IMMUNOPRECIPITATION 
          All steps were performed at 4oC if not denoted otherwise. For each 
immunoprecipitation, a bovine retina was incubated with 2ml of lysis buffer (100mM 
Tris HCl, pH 7.4, 150mM NaCl, 1mM EDTA) containing 1% TritonX-100 for 30 min 
at 4oC. Then the sample was centrifuged at 13,000 rpm for 15 mins at 4°C. 
Subsequently, the samples were transferred to 2ml syringes and forcefully ejected 
through 20 gauge needles to mechanically disrupt the retinal tissue. Mechanical 
crushing through 23gauge needles was repeated 40-50times. The mechanical 
disruption is essential to fractionate synaptic ribbons and to make them accessible for 
immunoprecipitation. Without mechanical treatment no RIBEYE Immunoreactivity 
was observed in the respective tissue lysate. After mechanical disruption, lysis was 
allowed to proceed for further 30min on ice. Afterwards, samples were centrifuged 
twice at 13,000 rpm for 30 min. The supernatant was incubated with 10 µl of GCAP2 
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pre-immune serum for 1 hour at 4oC and 20 µl of washed protein A-sepharose beads. 
Afterwards, the sample was centrifuged at 13,000 rpm for 15 min and the pre-cleared 
lysate was divided into two aliquot and incubated either with 10µl of GCAP2 immune 
serum  or with GCAP2 pre-immune serum (IgG control) together with 20µl of 
washed protein A sepharose beads (overnight). After overnight incubation, samples 
were centrifuged at 3,000rpm (2min) to pellet the protein A-sepharose beads. The 
pellet was washed three times with 1 ml of lysis buffer. The final pellet was boiled 
with SDS loading buffer and subjected to SDS-PAGE followed by western blotting.  
 
2.27. PURIFICATION SYNAPTIC RIBBON (Schmitz et al, 1996) 
2.27.1. Purification of photoreceptor synaptic complexes (OPL-fraction) 
 As a first step in the purification of photoreceptor synapses, a crude synaptic 
membrane fraction was prepared as described previously (Schmitz et al., 1993). 
Briefly, retinae freshly isolated from bovine eyes (obtained from a local 
slaughterhouse within 30 min post-mortem) and detached from pigment epithelium 
were disrupted by shear forces exerted by an ultraturrax for 3 min on ice (Type TP 
18/10; Janke and Kunkel, Staufen, Germany) in hypotonic homogenization buffer 
containing 15 mM Na2HPO4, pH 7.4, 1 mM EGTA, 1 mM MgCl2, and 1 mM 
phenylmethylsulfonyl fluoride for 3 min at 4°C. Thirty-five ml of homogenization 
buffer were used for eight isolated retinae. For preparation of crude synaptic 
membranes, 20 ml of homogenate was over layered on 10 ml of a sucrose cushion 
containing 50% sucrose (w/v) in homogenization buffer and centrifuged for 50 min at 
15,000 rpm (~27,200 × gmax) at 4°C in a JA20 rotor (Beckman, Palo Alto, CA). At the 
interface between the sucrose cushion and the supernatant, a broad opaque band of 
membranes was visible and used for the subsequent purification of photoreceptor 
synapses. This band was removed carefully with a Pasteur pipette and diluted with 
approximately twofold its volume with homogenization buffer. This diluted 
suspension was spun in a JA20 rotor at 20,000 rpm (~48,400 × gmax) for 10 min 
(4°C). The supernatant was discarded, and the pellet was resuspended with 
approximately the same volume of homogenization buffer. For convenience, this 
resulting membrane suspension containing crude synaptic membranes (CSMs) was 
denoted CSM-fraction. The CSM-fraction was over layered on a linear sucrose 
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gradient ranging from 35 to 50% sucrose (w/v) in homogenization buffer. Membranes 
were spun at 13,000 rpm (~30,000 × gmax) for 1.5 hr at 4°C in an SW40 rotor. After 
this spin, two bands and a large pellet were visible. A membrane fraction that was 
recovered as a broad band at a sucrose density of ~40% (w/v) in homogenization 
buffer (sucrose density calculated by its distance between the top and bottom of the 
gradient) was denoted OPL-fraction and characterized as described below. Membrane 
fractions were analyzed by Immunoblotting and immunofluorescence microscopy 
with the ribbon antiserum. To analyze the retinal fractions by immunofluorescence, 
microscopy samples were diluted with the twofold volume of homogenization buffer, 
sedimented in an Eppendorf centrifuge (model 5415C, Eppendorf, Hamburg, 
Germany) at 14,000 rpm (~15,900 × gmax) at 4°C for 10 min, and flash-frozen in 
liquid nitrogen. From these frozen samples, 10-µm-thick cryostat sections were cut 
and immunolabeled with the ribbon antiserum as described above.  
2.27.2. Purification of synaptic ribbons from the OPL fraction  
 OPL membranes were diluted with the twofold volume of homogenization 
buffer and spun in a JA20 rotor at 11,000 rpm (~14,600 × gmax) for 10 min at 4°C. 
The resulting sediment was resuspended in homogenization buffer containing 1% 
Triton X-100 (w/v) to a protein concentration of ~1 mg/ml. The pellet was 
homogenized three times with a tight-fitting Teflon pestle and kept on ice for ~30 
min. After this incubation period, the Triton-insoluble fraction of photoreceptor 
synapses was sedimented in a JA20 rotor at 11,000 rpm (~14,600 × gmax) for 10 min 
at 4°C. The sediment was resuspended with approximately the same volume of 
homogenization buffer containing 20% sucrose. This suspension was over layered on 
a sucrose step gradient containing 2 ml of each of the following sucrose 
concentrations (in homogenization buffer): 30, 40, 50, and 70%. Then the sample was 
centrifuged in an SW40 rotor at 11,000 rpm (~20,000 × gmax) for 75 min at 4°C. The 
opaque protein bands at the respective interfaces of the sucrose step gradient were 
tested for the presence of synaptic ribbons by immunofluorescence and electron 
microscopy. The retinal subfraction between the 50 and 70% sucrose step contained 
the highest density and purity of synaptic ribbons and was denoted SR-fraction. 
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2.28. GST pull down assay in the presence of NAD+/NADH 
           GCAP2-GST or GST alone bound to glutathione agarose beads as an 
immobilized bait protein and the eluted RE (B)-MBP or MBP alone as a prey protein 
were used for this assay. The eluted RE(B)MBP were incubated with GCAP2-GST   
in equimolar concentration (0.8µM) in a total volume of 500 µl incubation 
buffer(100mM Tris-HCl(pH 8.0), 150mM NaCl,1mM EDTA and 0.25% Triton X-
100). The NADH or NAD+ was added as an increasing concentration ranging from 
1nM-20µM in the incubation mixture of GCAP2-GST and RE(B)-MBP. These 
samples were incubated for 5 to 6 hrs at 4º C. Then, the samples were centrifuged and 
the pellets were washed 3 times with incubation buffer. Every washing step was 
followed by centrifugation at 3,000 rpm for 2 mins at 4º C. The pellet was boiled in 
SDS-PAGE loading buffer at 96º C for 5 mins. The eluted proteins were subjected to 
10% SDS-PAGE . 
 
2.29. Preabsorption experiments 
        Preabsorption for western blotting: 50µl of GCAP2 immune serum (6th immune 
serum) was added to GST-GCAP2 (20µg) and GST (20µg) fusion protein bound to 
beads in a final volume of approx. 75 l and incubated overnight at 4oC in an 
overhead rotator. After incubation, samples were centrifuged at 13,000rpm for 3 mins 
at 4ºC and the respective supernatants were taken for the subsequent experiments. For 
western blot analyses of bovine crude retinal extract the two preabsorbed antisera 
described above were used at a dilution of 1:1,000 in blocking buffer (5% skim milk 
powder in PBS).  
 
2.30. Preabsorption for immunofluorescence 
         Pre-absorption with fusion protein for immunofluorescence microscopy was 
done as described above for western blotting. The preabsorbed antisera (preabsorbed 
either with GST or GCAP2-GST) were subsequently tested at identical dilutions for 
immunolabeling on cryostat sections of the bovine retina. 
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2.31. Immunolabeling analyses 
Immunolabeling analyses were performed as previously described (Schmitz et 
al., 2000, 2006; Alpadi et al., 2008) using a Zeiss inverted Axiovert200M microscope 
(Carl Zeiss) equipped for conventional epifluorescence microscopy. In brief, 10µm 
thick cryostat sections were heat-fixed for 10 mins at 50oC and subsequently treated 
with 0.5% BSA for 1hr (RT) before the primary antibodies were applied at the 
indicated dilutions (see also section 2.7). Primary antibodies were usually applied 
overnight at 4oC if not indicated otherwise. After removing unbound antibody by 
several washes with PBS, secondary antibodies were applied at the dilutions in PBS 
(1hr, RT). After removing unbound antibody with PBS sections were mounted in 
NPG-antifade (Magupalli et al., 2008). Incubations only with secondary antibody 
(without primary antibody) and irrelevant primary antibodies served as negative 
controls. 
 
2.32. Double-labeling of cryostat sections of the bovine retina with GCAP2 
antibodies and Peanut agglutinin (PNA) 
         Cryosection of bovine retina were heat fixed  for 10 min @ 50o C and incubated 
with blocking buffer containing (0.5 % BSA, 0.02 % Triton X -100 in PBS) at RT for 
45 mins. Section were then incubated with primary polyclonal GCAP2 antibody at a 
1:500 dilution in blocking buffer overnight, 4oC. After brief washing with blocking 
buffer, sections were incubated with secondary antibody GAR-Cy3 (1hr, RT). Section 
were next incubated with Peanut aggulutinin (PNA)–Alexa 488 (1:250 dilution) in 
blocking buffer for 3hrs at RT. After washing once with PBS, sections were mounted 
in NPG-antifade for microscopic analysis. 
 
2.33. Genereration of recombinant Semliki-Forest Virus  
   2.33.1. Cell culture 
     BHK-21 cells were cultured in OPTIMEM/GlutaMax™ medium (Gibco) 
supplemented with 10 % (v/v) tryptose phosphate broth, 20 mM HEPES, 2.5 % FCS 
at 37 °C, 5 % CO2, and used between passage numbers 5 to 25. 
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  2.33.2. Generation of recombinant SFV particles  
   The Semliki forest virus expression vector GCAP2-EGFPpSFV was 
constructed in three steps. First, PCR was used to generate a BglII-BamHI flanked 
EGFP fragment using the following forward and reverse primers: forward (5’-
TTTAGATCTGCCACCATGGTGAGCAAGGGCGA) and reverse (5’-
TTTGGATCCCTTGTACAGCTCGTCCAT) for ligation into the BamHI site of the 
pSFV1 expression vector. Next, a BamHI-BssHII flanking GCAP insert was 
amplified by PCR (5’-TTTTGGATCCATGGGGCAGCAGTTCAGC, forward 
primer), (5’- TTTTGCGCGCTCAGAACATGGCACTTTTCC, reverse primer) and 
GCAP2(aa1-204)pGEX as a template. The PCR product was cloned into the BamHI-
BssHII site of EGFPpSFV (Ashery et al., 1999). The IRES site of pSFV was deleted  
by digestion with BssHII-ClaI, fill-in with Klenow and religation of the vector. 
EGFPpSFV was used as control plasmid/control virus (Ashery et al., 1999). mRNA 
was generated from pSFV1 expression vector (GCAP2-EGFPpSFV; EGFPpSFV) and 
pSFV2 helper vector by linearizing both vectors with SpeI and in-vitro transcription 
using SP6 RNA polymerase according to the manufacturer’s instructions (mMessage 
mMachine SP6- Kit, Ambion). 10g of purified mRNA was electroporated into 1 
x107 BHK-21 cells in OPTIMEM/GlutaMax™ medium without supplements at 
360V, 75 µF and pulsed twice using a Bio-Rad GenePulser II apparatus. Cells were 
resuspended in 10 ml of complete OPTIMEM/GlutaMax™ growth medium (see 
under A) and plated for 24hrs at 31°C, 5% CO2. Medium was recovered from the 
flasks and centrifuged at 400xg for 5 mins. The supernatants were aliquoted and 
stored at -80°C. Virus titer of the virus suspensions was determined exactly as 
previously described (Ashery et al., 1999).  
    
2.33.3. Infection of mouse organotypic retinal cultures 
 The virus-containing stock was supplemented with an equal volume of OPTIMEM/ 
GlutaMax™ containing 0.2% BSA. Virus was activated by the addition of 
chymotrypsin (0.2 mg/ml, Sigma-Aldrich) and subsequent incubation for 40 mins at 
room temperature. Proteolytic activation of the virus was stopped by the addition of 
aprotinin (0.6 mg/ml, Sigma-Aldrich). Organotypic retina cultures were incubated 
with the respective virus (4-5x107 infectiuos units/ml) for 16-24hrs at 31oC, 5% CO2, 
before being replaced by normal growth medium. 
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2.34. Organotypic culture of retinal explants 
Preparation of organotypic cultures was performed largely as previously described 
(Fischer et al., 2000; Pérez-León et al., 2003; Zhang et al, 2008), with some 
modifications. Briefly, freshly isolated eyes enucleated from adult mice housed under 
ambient light conditions were immediately immersed into ice-cold RPMI 1640 
(supplemented with 10 % fetal calf serum, 10 mM HEPES, 2 mM L-glutamine, 1 mM 
sodium pyruvate, and 50 µM ß-mercaptoethanol, 100U/ml penicillin and 100µg/ml 
streptomycin). The anterior portion of the eye was removed by incision along the ora 
serrata. After removal of lens and vitreous body, the optic nerve was cut and the 
retina subsequently gently removed from the posterior eyecup. The retina was 
mounted photoreceptor side down on PET (polyethylene terephthalate) cell culture 
inserts (8,0 µm pore size, Falcon) placed in six-well plates containing 1ml of RPMI 
1640 with the above described supplements. Explants were incubated for 1h at 
31°C/5% CO2 and then infected with recombinant Semliki Forest virus. For infection 
with recombinant Semliki Forest virus, RPMI1640 medium was replaced by 1ml of 
the activated virus solution (see above, virus titer typically between 4-5 ×107 
infectious units per ml) and incubated overnight at 31°C /5% CO2. After 16-24hrs of 
infection, the virus-containing medium was removed from the cell culture dishes by 
three washes with RPMI (with supplements). The explants were allowed to recover 
for several hours before being processed for whole mount immunostaining. 
 
2.35. Whole mount immunostaining of organotypic retinal explants 
 One day after infection retinal explants were fixed in 4% PFA for 20 min at 4°C. 
Explants were permeabilized for 30 min at RT in incubation buffer (PBS with 0.3% 
Tx-100 and 0.5% BSA) and subsequently incubated with primary antibody (U2656, 
1/500 diluted in incubation buffer) overnight at 4°C. Unbound antibody was removed 
by intensive washing with washing buffer (PBS, 0.5%Tween-20, 0.5% BSA). 
Explants were then incubated with the indicated fluorophore-conjugated secondary 
antibody (1/1000 in incubation buffer; see also section 2.7) ovenight at 4°C. Unbound 
antibody was again removed by intensive washing with washing buffer. Explants 
were then fixed with 4% PFA (15 mins, 4oC), cut with a cryostat (10µm-thick 
sections) and thawed on uncoated SUPERFROST coverslides. Sections were 
analyzed with a Zeiss Axiovert200M microscope equipped with an apotome and the 
respective filter sets (EX BP 450-490nm/BS FT510/EM BP 515-565; EX BP 
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546/12/BS FT 580/EM LP 590). For counting terminals were observed in the 
apotome mode. 
 
2.36. 3D-reconstruction of immunolabeled structures in retinal explants 
For 3D-reconstructions retina sections were observed with the Zeiss Axiovert200 
microscope. Z-stacks were taken using the apotome and 3D-reconstruction was 
performed using the Inside4D software module from Zeiss. 
 
2.37. In-situ Proximity Ligation Assays (In-situ PLA) 
 Proximity ligation assays are a highly sensitive and specific way to detect protein-
protein interaction in-situ e.g. in tissue sections (Gustafsdottir et al., 2005; Söderberg 
et al., 2006, 2008). Proximity ligation reactions critically depends on the distance of 
the two interaction partners. Positive PLA interaction signals indicate that the 
interacting proteins are localized in less than 40 nm distance from each other 
(Söderberg et al., 2006). PLA assay components (Gustafsdottir et al., 2005) were 
purchased from Eurogentec and performed according to the manufacturer’s 
instructions. The following components were purchased from Eurogentech: anti-
rabbit immunoglobulins coupled to the “PLUS” oligonucleotide (PLA PLUS probe), 
anti-mouse immunoglobulins PLA “MINUS” probe and the fluorescence detection kit 
563 containing the linker oligonucleotide, enzymes for rolling circle amplification 
and fluorescent probe for product detection. In brief, 10µm thick sections of flash-
frozen mouse eyes (prepared as described above) were heat-fixed for 10 mins at 50oC 
and subsequently treated with the Duolink blocking solution supplied by the 
manufacturer (Olink Biosciences, Eurogentech, Belgium) for 30 mins at 37oC. Next, 
sections were incubated with primary antibody dilutions (in Duolink antibody dilution 
solution; Olink Bioscience; Eurogentech, Belgium). The following antibodies were 
used at the indicated dilutions: polyclonal rabbit GCAP2 antibody (1:500); 
monoclonal anti-RIBEYE(B)/CtBP2 (BD) (1:500); polyclonal rabbit RIBEYE 
antibody (U2656, 1:500); mouse monoclonal antibody against opsin (Rho1D4, 
1:500); polyclonal antibody against mGluR6 (Neuromics/Acris antibodies, RA13105) 
(1:500). Duolink in-situ PLA were performed as described by the manufacturer: After 
incubation with the primary anibodies, combinations of the PLA probes (anti-rabbit 
PLUS probe, anti-mouse MINUS probe: both diluted 1:8 in Duolink antibody dilution 
buffer) were added to the sections for 2hrs at 37oC in a wet chamber. After washing 
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the sections with TBS (2x5mins) hybridization with the linker oligonucleotide was 
performed for 15 mins at 37oC. Tissue was washed for 1min with TBS before ligation 
was performed for 15 mins at 37oC in a humid chamber. After washes with TBS for 5 
mins, rolling circle amplification was done for 90 mins at 37oC precisely following 
the manufacturer’s protocol. The product of the rolling circle amplification was 
detected with the Duolink detection kit 563 (Olink Bioscience, purchased via 
Eurogentech, Belgium) using Duolink fluorophore 563-labeled oligonucleotide 
diluted 1:5 with H2O. The detection reaction was performed for 60 mins at 37oC. As 
negative controls, PLA assays were done without primary antibodies or with only one 
primary antibody. Sections were subsequently washed with 2x SSC (2mins), 1xSSC 
(2mins), 0.2xSSC (2mins) and 0.02x SSC (1min). Afterwards, sections were mounted 
with Duolink mounting medium, sealed with a coverslip and analyzed by 
epifluorescence microscopy as described above. As further control to test for the 
spatial sensitivity/proximity requirements  of the in-situ PLA reactions we also 
analyzed for PLA signals between a presynaptic marker (RIBEYE) and a postsynaptic 
marker at the tips of invaginating ON-bipolar cells (mGluR6). As positive controls we 
used acombination of the following two antibodies (rabbit polyclonal RIBEYE 
U2656/mouse anti-RIBEYE(B)/CtBP2) (Fig. 20L) and mouse monoclonal anti-opsin 
(Rho1D4)/rabbit polyclonal GCAP2) (Fig. 20K). The antibodies that were used in the 
Olink PLA assays are summarized as following with their indicated working 
dilutions: rabbit polyclonal GCAP2 antibody (1:500); Rabbit polyclonal antibody 
against RIBEYE U2656 (1:500); rabbit polyclonal antibody against mGluR6 (1:500); 
mouse monoclonal antibody against RIBEYE(B)/CtBP2, mouse monoclonal antibody 
against opsin (Rho1D4) (1:500). Antibody combinations were used as indicated in 
Fig. 20. 
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3.1. Identification of GCAP2 as a RIBEYE interacting protein 
       In order to identify novel RIBEYE interacting proteins, RIBEYE (B)-domain (aa 
564-988) was used as bait in YTH screen of a bovine retina cDNA library. The 
GCAP2 prey clone we obtained started at histidine H95 of bovine GCAP2 
(GCAP2(95-204) and coded for the two carboxyterminal EF hands and the 
carboxyterminal region (CTR) of GCAP2. The interaction was confirmed by growth 
of mated yeast on -ALWH selective plates and the expression of - galactosidase 
marker gene activity. The prey clone was not auto-activating as judged by the 
respective control matings (Fig. 9C) and thus pointed to an interaction between 
RIBEYE and GCAP2 in the YTH system. In order to further consolidate these finding 
we cloned full-length GCAP2 and the indicated GCAP2 constructs from bovine 
retinal cDNA into the respective yeast vectors and tested them for interaction with 
RIBEYE(B) in the YTH system (Fig.9C). The GCAP2 constructs were designed 
based on the known domain structure of GCAP2 (Fig. 9D). All of the tested GCAP2 
constructs-except for full-length GCAP2 with an intact aminoterminal myristoylation 
signal- interacted with RIBEYE(B) (Fig.9). Full-length GCAP2 with intact 
aminoterminal myristoylation signal encoded by the first two amino acids (MG) did 
not interact with RIBEYE (Fig. 9C, D). If the aminoterminal myristoylation signal in 
full-length GCAP2 was deleted by deleting the two aminoterminal amino acids 
GCAP2 interacted with RIBEYE(B) in the YTH system (Fig. 9D). Thus, the 
myristoylation of GCAP2 at glycin G2 and the resulting membrane association 
prevent GCAP2 from entering the nucleus  were the interaction needs to take place in 
the Gal4-based YTH system. This finding confirmed the interaction between 
RIBEYE(B) and GCAP2. This was further addressed by deletion mapping using 
RIBEYE(B) and GCAP2 deletion constructs. The mapping analyses revealed that 
RIBEYE interacted with GCAP2 even when all EF-hands of GCAP2 were deleted by 
aminoterminal truncations (Fig. 9). The carboxyterminal region of GCAP2 that starts 
after the fourth EF hand (abbreviated as CTR in the following text) retained the 
capability to interact with RIBEYE(B) in the YTH system. Therefore, we conclude 
that the CTR of GCAP2 mediates the interaction with RIBEYE. 
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Figure  9.  RIBEYE interacts with GCAP2 in the YTH system. 
A) Sequence of bovine GCAP2 given in the single letter amino acid code. The 4 EF hands of GCAP2 are indicated 
in color. EF hand 1 (colored in yellow) is non-functional and does not bind Ca2+; EF hands 2-4 (colored in green) 
are functional and do bind Ca2+. The bold bar that underlines the schematic drawing of GCAP2 denotes the 
extension of the obtained GCAP2 prey clone (see also Fig. 1D, prey 4). B) Domain structure of RIBEYE. 
RIBEYE consists of an aminoterminal A-domain and a carboxyterminal B-domain. The B-domain can be further 
subdivided into a contiguous central NAD(H)-binding sub-domain (NBD) and a discontinuous substrate-binding 
sub-domain (SBD). The SBD consists of two sequence stretches, SBDa and SBDb, that are linked to the NBD via 
two flexible hinge regions, hinge 1 and hinge 2 (see also Fig. 4A,B). C) GCAP2 interacts with RIBEYE(B) in the 
YTH system. Summary plates of YTH analyses obtained with the indicated bait and prey plasmids. For 
convenience, experimental bait-prey pairs are underlayered in color (green in case of interacting bait-prey pairs; 
yellow in case of non-interacting bait-prey pairs); control matings are non-colored. RIBEYE(B) interacts with 
GCAP2 as judged by growth on selective plates (-ALWH) and expression of -galactosidase expression (yeast 
matings #4,7,13,16,19,22; Fig. 1C). The respective control matings (auto-activation controls; yeast   matings # 2-3,  
5-6,  8-11, 14-15, 17-18, 20-21, 23-24)  did  not  show  growth  on -ALWH plate and no expression of -
galactosidase activity. Growth on –LW plates (Fig. 1C) demonstrates the presence of the bait and prey plasmids in 
the mated yeasts. Full-length GCAP2 containing an intact myristoylation site did not interact with RIBEYE(B) 
(mating #1, Fig.1C) because the myristoylation prevents the entry of the prey protein into the nucleus (see text). If 
the myristoylation signal is deleted by a point mutation (G2A) full-length GCAP2 also interacts with RIBEYE(B) 
(Suppl. Fig. 1). Similarly, deleting the myristoylation signal by truncation of the first two amino acids also results 
in interaction between RIBEYE(B) and GCAP2 (mating #4; Fig. 1C). Mating #12 is an unrelated positive control 
mating (Alpadi et al., 2008). D) Schematic summary of the mapping analyses obtained with the YTH system. 
RIBEYE(B) interacts with all tested GCAP2 constructs except for full-length GCAP2 that contains an intact 
myristoylation signal (prey 1). If the myristoylation signal is deleted by a point mutation (G2A) (prey 2, Fig. 1D) 
full-length GCAP2 also interacts with RIBEYE(B). 
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3.2. RIBEYE interacts myristoylation deficient full-length GCAP2 
All of the tested GCAP2 constructs -except for full-length GCAP2 with an 
intact aminoterminal myristoylation signal- interacted with RIBEYE(B) (Fig. 9C,D) 
in the YTH system. If the aminoterminal myristoylation signal in full-length GCAP2 
(encoded by the first aminoterminal amino acids: MG) was deleted by point-mutating 
glycine 2(G2) into alanine (G2A), GCAP2 interacted with RIBEYE(B) in the YTH 
system (Fig.10). Thus, the myristoylation of GCAP2 at glycine G2 and the resulting 
membrane association prevent GCAP2 from entering the nucleus where the 
interaction needs to take place in the Gal4-based YTH system. 
 
 
Figure 10. RIBEYE interacts with myristoylation-deficient full-length GCAP2.  
Summary plates of YTH analyses obtained with the indicated bait and prey plasmids. For convenience, 
experimental bait-prey pairs are underlayered in color (green in case of interacting bait-prey pairs; yellow in case 
of non-interacting bait-prey pairs); control matings are non-colored. RIBEYE(B) interacts with myristoylation-
deficient full-length GCAP2 (GCAP2(1-204)G2A) as judged by growth on selective plates (-ALWH) and 
expression of -galactosidase activity (yeast mating #1). The respective control matings (auto-activation controls; 
yeast  matings #2 - 5, #7 - 8)  did  not show growth on -ALWH selective plates and expression of -galactosidase 
activity. RIBEYE(B) does not interact with full-length GCAP2 with an intact myristoylation signal (mating #6). 
Mating #9 is a positive control. 
 
3.3. Mutation of the CTR of GCAP2 abolish interaction with RIBEYE(B) 
The carboxyterminal region of GCAP2 that starts after the fourth EF-hand 
retained the capability to interact with RIBEYE(B) in the YTH system. Therefore, we 
conclude that the CTR of GCAP2 mediates the interaction with RIBEYE. This 
assumption is further supported by our finding that point mutants of the CTR 
GCAP2(171-204)E172D of GCAP2  no longer interacted with RIBEYE(B). 
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Figure 11. Mutations of the carboxyterminal region (CTR) of GCAP2 abolish interaction with RIBEYE. 
Summary plates of YTH analyses obtained with the indicated bait and prey plasmids. For convenience, 
experimental bait-prey pairs are underlayered in color (green in case of interacting bait-prey pairs; yellow in case 
of non-interacting bait-prey pairs); control matings are non-colored. RIBEYE(B) does not interact with a point-
mutated CTR of GCAP2, GCAP2(171-204)E172D (matings #1, #6), although it interacts with the wildtype CTR, 
GCAP2(171-204) (Fig. 1). The respective control matings (auto-activation  controls;  yeast  matings  # 2-5, # 7-8)  
did  not show growth on -ALWH selective plates and expression of -galactosidase activity. Mating #9 is a 
positive control. RE(B)856-891 encodes for the hinge 2 region of RIBEYE(B) which was shown to be responsible 
for interaction with GCAP2 (Fig. 3). 
 
3.4. GCAP2 does not interact with SBD and NBD of RIBEYE(B) 
The B-domain of RIBEYE consists of a NAD(H)-binding sub-domain (NBD) 
and a substrate-binding sub-domain (SBD). In order to map which parts of 
RIBEYE(B) are important for interaction with GCAP2 we tested whether the SBD 
and NBD of RIBEYE alone can interact with GCAP2. Surprisingly, both the SBD 
and NBD alone did not interact with GCAP2 in the YTH system (Fig. 12B).  
                              A 
                                
Figure  12A) Structure model of the B-domain of RIBEYE based on the crystal structure of tCtBP1 (Kumar et al., 
2002; Nardini et al., 2003; see also Magupalli et al., 2008; Alpadi et al., 2008). The B-domain of RIBEYE consists 
of a NAD(H)-binding sub-domain (NBD) and a substrate-binding sub-domain (SBD) 
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Figure  12B. GCAP2 not interact with the NBD and SBD of RIBEYE(B). 
Summary plates of YTH analyses obtained with the indicated bait and prey plasmids. For convenience, 
experimental bait-prey pairs are underlayered in color (green in case of interacting bait-prey pairs; yellow in case 
of non-interacting bait-prey pairs); control matings are non-colored. GCAP2 interacts with intact RIBEYE(B) as 
judged by growth on selective plates (-ALWH) and expression of -galactosidase expression (yeast mating #1; 
positive control). In contrast, GCAP2 does not interact either with the NBD (mating #2) or the SBD (mating #3) of 
RIBEYE alone. The respective control matings (auto-activation controls; yeast matings # 4 - 11) did not show 
growth on -ALWH plates and expression of -galactosidase activity. Growth on –LW plates (Fig. 2C) 
demonstrates the presence of the bait and prey plasmids in the mated yeasts. 
 
3.5. GCAP2 interacts with flexible region of hinge2 region of RIBEYE(B) 
Since the NBD- and SBD- constructs used above did not contain the 
connecting hinge regions, hinge 1 and hinge 2, we tested next whether the hinge 
regions of RIBEYE might mediate interaction with GCAP2. Indeed, the hinge 2 
region of RIBEYE interacted with GCAP2 whereas the hinge 1 region did not in the 
YTH system (Fig. 13B) Therefore, the flexible hinge 2 region that connects the NBD 
with the SBD is the essential binding site for GCAP2 (Fig. 13A).  
                  A                                          
                    
Figure  13A. Structure model of the B-domain of RIBEYE. 
Based on the crystal structure of tCtBP1 (Kumar et al., 2002; Nardini et al., 2003; see also Magupalli et al., 2008; 
Alpadi et al., 2008). The B-domain of RIBEYE consists of a NAD(H)-binding subdomain (NBD) and a substrate-
binding subdomain (SBD) which are connected by two flexible hinge regions, hinge 1 and hinge 2 (colored in 
blue). The dotted lines indicate the extensions of the hinge 1 and hinge 2 constructs tested in Fig. 5B with the YTH 
system 
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 Figure  13B.  GCAP2 interacts with the hinge 2 region of RIBEYE(B). 
 Summary plates of YTH analyses obtained with the indicated bait and prey plasmids. For convenience, 
experimental bait-prey pairs are underlayered in color (green in case of interacting bait-prey pairs; yellow in case 
of non-interacting bait-prey pairs); control matings are non-colored. GCAP2 interacts with the hinge 2 region of 
RIBEYE(B)856-891 (yeast matings #3, #6, #9) but not with the hinge1 region of RIBEYE(B)663-691 (yeast 
matings #2, #5, #8) as judged by growth on selective plates (-ALWH) and expression of -galactosidase activity. 
The respective control matings (auto-activation controls; yeast matings #10-21) did not show growth on -ALWH 
plate and expression of -galactosidase activity. Growth on –LW plates (Fig. 2B) demonstrates the presence of the 
bait and prey plasmids in the mated yeasts. Mating #1 represents a positive control mating (RE(B)/GCAP2; see 
also Fig. 1). Mating #22 represents an unrelated positive control mating (Alpadi et al., 2008). Abbreviations: 
NBD, NAD(H)-binding sub-domain of RIBEYE(B); SBD, substrate-binding sub-domain of RIBEYE(B). 
 
3.6. Point mutants of the hinge2 region of RIBEYE(B) disrupt interaction with 
GCAP2 
The hinge 2 region (aa856-aa891) of RIBEYE(B) interacted with GCAP2 
whereas the hinge 1 region (aa663-691) did not (Fig. 13B). Therefore, the flexible 
hinge 2 region that connects the NBD with the SBDb is the essential binding site for 
GCAP2 (Fig. 13A). This assumption is further supported by the analysis of point 
mutants of the hinge 2 region, i.e. RIBEYE(B)W867E and RIBEYE(B)T856S (Fig. 
14A). These points mutants of the hinge 2 region of RIBEYE(B) no longer interacted 
with GCAP2 in the YTH system(Fig. 14B).  
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Figure 14A. Structure model of RIBEYE(B)-domain in which the interface region between NBD and SBD is 
magnified. W867 and T865 indicate amino acid residues within the hinge 2 region that disrupt interaction with 
GCAP2 when mutated. The hinge 2 region with W867, T865 and bound NAD(H) are colored in blue. W867 is 
located close to the nicotinamide moiety of NAD(H). 
 
 
Figure 14B. point mutants of the hinge 2 region of RIBEYE(B) disrupt interaction with GCAP2.   
Summary plates of YTH analyses obtained with the indicated bait and prey plasmids. For convenience, 
experimental bait-prey pairs are underlayered in color (green in case of interacting bait-prey pairs; yellow in case 
of non-interacting bait-prey pairs); control matings are non-colored. Point mutants of the RIBEYE(B) hinge 2 
region RE(B)T865S and RE(B)W867E do not interact with GCAP2 (matings #1-3, #15-17). The respective 
control matings (auto-activation controls; yeast matings #4-11, #18-25) did not show growth on -ALWH selective 
plates and expression of -galactosidase activity. Matings #12-14, 26-28 are positive control matings. 
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3.7. The A-domain of RIBEYE does not prevent GCAP2/RIBEYE(B) interaction 
   RIBEYE expresses endogenously as full length (A+B domain) in the retina. 
Therefore, we  tested whether the full length RIBEYE (contains both A domain and B 
domain) also interacted with GCAP2. RE(AB) also shows interaction with GCAP2 
indicating that the A-domain of RIBEYE is not inhibiting the interaction of RIBEYE 
(B)-domain with GCAP2 (Fig.15). In YTH assay, the confirmation of bait and prey 
plasmids in the yeast was confirmed by growth on –LW plates. The interactions were 
judged by the growth on -ALWH selection plates, selective for protein interaction 
(Fig.15) by qualitative assessment of -galactosidase marker gene expression. 
 
 
Figure 15. The A-domain of RIBEYE does not prevent GCAP2/RIBEYE(B) interaction.   
Also full-length RIBEYE (RE(AB)) and not only RIBEYE(B) interacts with GCAP2 indicating that the A-domain 
of RIBEYE does not prevent RIBEYE(B)/GCAP2 interaction. For convenience, experimental bait-prey pairs are 
underlayered in color (green in case of interacting bait-prey pairs; yellow in case of non-interacting bait-prey 
pairs); control matings are non-colored. RIBEYE(AB) interacts with GCAP2 (matings #1-6). The respective 
control matings (auto-activation controls; yeast matings #7-20) did not show growth on -ALWH selective plates 
and expression of -galactosidase activity. Mating #21 is an interaction positive control mating. 
 
 
3.8. GCAP2 binds to monomeric RIBEYE(B) and GCAP2 binding is 
independent upon RIBEYE(B) homodimerization 
RIBEYE(B) is known to homo-dimerize (Magupalli et al., 2008). Analyses of 
a RIBEYE(B)-dimerization deficient mutant RIBEYE(B)∆HDL (Magupalli et al., 
2008), revealed that RIBEYE(B)-GCAP2 interaction does not require RIBEYE(B) 
homo-dimerization. RIBEYE(B)∆HDL interacted with GCAP2 in the YTH system ( 
Fig. 16). Therefore, GCAP2 can interact with monomeric RIBEYE(B).  
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Figure 16. GCAP2 binds to monomeric RIBEYE(B).  
For convenience, experimental bait-prey pairs are underlayered in color (green in case of interacting bait-prey 
pairs; yellow in case of non-interacting bait-prey pairs); control matings are non-colored. RIBEYE(B)∆HDL 
interacts with GCAP2 (mating #2) although it does not interact with RIBEYE(B) (mating #4). The respective 
control matings (auto-activation controls; yeast matings #5-14) did not show growth on -ALWH selective plates 
and expression of -galactosidase activity. Mating #1 is the interaction positive control mating. Mating #3 
represents an unrelated positive control mating demonstrating proper folding of the dimerization-deficient 
RIBEYE(B) mutant (Alpadi et al., 2008). 
 
3.9. GCAP2 interacts with RIBEYE(B) in fusion protein pull-down assays 
The YTH analyses demonstrated RIBEYE/GCAP2 interaction in the YTH 
system. In order to verify this interaction also by further independent approaches we 
first performed fusion protein pull-down analyses (Fig. 17). GST-tagged GCAP2 was 
used as an immobilized bait protein. GST alone served as control protein. 
RIBEYE(B)-MBP or MBP alone (control protein) were used as soluble prey proteins. 
GST-GCAP2 (but not GST alone) pulled down RIBEYE(B)-MBP (but not MBP 
alone) demonstrating a specific interaction between RIBEYE(B) and GCAP2 (Fig. 
17). The binding between RIBEYE(B)-MBP and GST-GCAP2 as shown by both  
coomassie staining of SDS PAGE as well as by western blot analysis with respective 
antibodies (Fig. 17A,B). In western blotting, the membrane was first incubated with 
anti- MBP to show the binding of RIBEYE (B) to GST-GCAP2     (Fig. 17Ba) and 
then the same blot was incubated with anti-GST (after stripping) to demonstrate the 
equal loading of bait proteins (Fig. 17Bb). Based on semiquantitative evaluation 
GCAP2-GST pulled-down at least ~15% of total RIBEYE(B)-MBP in these 
experiments. Using quantification of the bound proteins, we estimate a KD of 2,72 
(+/-0.19) x10-6 mol/L for GCAP2/RIBEYE interaction. 
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 Figure 17A. RIBEYE(B) interacts with GCAP2 in protein pull-down analyses. 
GCAP2-GST and GST alone (control protein) were used as immobilized bait proteins and RIBEYE(B)-MBP and 
MBP alone (control protein) as soluble prey proteins. After incubation and subsequent washing of the immobilized 
proteins, binding of the soluble prey proteins to the immobilized prey proteins was tested by SDS-PAGE (10% 
polyacrylamide gels) in (A).  RIBEYE(B)-MBP binds to GCAP2-GST (lane 9, arrowhead) but not to GST alone 
(lane 8). MBP alone does not bind to either GCAP2-GST (lane 7) or GST alone (lane 6). 10% of the total proteins 
were loaded in the input lanes (lanes 2-5); 100% of the immobilized protein pellets were loaded (lanes 6-9). 8% of 
the unbound fraction (marked by asterisk) was loaded in lane 1. 
 
 
 
             
 
Figure 17B. RIBEYE(B) interacts with GCAP2 in protein pull-down analyses(Western blot).  
Figure 17Ba. RIBEYE(B)-MBP binds to GCAP2-GST (arrowhead in lane 8) but not to GST alone (lane 7). It 
shows specific interaction of GCAP2/RIBEYE(B). Lane 3 and lane 4 are input fractions. Figure 17Bb shows the 
same blot as in Fig. 3Ba but after stripping and reprobing of the nitrocellulose with anti-GST antibodies to show 
equal loading of bait proteins. In (Fig. 3Ba,b) 10% of the input (lanes 1-4) was loaded. Always 100% of the 
immobilized protein pellets were loaded (lanes 5-8).   
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3.10. Characterisation of GCAP2 antibody 
         A polyclonal antibody against full-length bovine GCAP2-fusion protein was 
generated in rabbits by using purified, bacterially expressed GST-tagged full-length 
bovine GCAP2(1-204) as antigen(fig. 18).  
                                                  
   Figure 18. Expression of GST-GCAP2 fusion protein. 
   Coomassie Blue-stained SDS-PAGE shows the expression of GST-GCAP2 (49kDa) fusion protein        
   which is expressed in BL21 electrocompetent bacterial cell 
 
The 6th immune bleed (obtained 90 days after initial immunization) was used in the 
present experiments. The polyclonal GCAP2 antibody raised against full-length 
GCAP2 cross-reacts with GCAP1 (Fig. 19). A mouse monoclonal antibody against 
human GCAP2 that reacts with bovine GCAP2 but not with bovine GCAP1 (Fig. 22) 
was purchased from Santa Cruz (clone A1, sc-59543).  
 
                                     
 Figure 19.Polyclonal GCAP2 antiserum cross-reacts with GCAP1. 
 The polyclonal GCAP2 antiserum (generated against full-length bovine GCAP2 tagged with GST) detects 
GCAP2-GST (lane 4) as well as GCAP2 in bovine retinal extracts (lane 6). It also cross-reacts with GCAP1 
(tested with purified GCAP1-MBP fusion protein lane 2). This cross-reactivity of the polyclonal GCAP2 immune 
serum with GCAP1 is not surprising because GCAP1 and GCAP2 are highly homologous (for review, see 
Palczewski et al., 2004). The GCAP2 pre-immune serum does not detect any protein band in the bovine retina 
(lane 7) and does not react with purified GCAP2-GST fusion protein (not shown). 
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3.11. Detection of GCAP2 in the bovine retina can be blocked by GCAP2-GST 
pre-absorption but not by GST pre-absorption. 
            The GCAP2 immunosignals were specific because the signal could be 
completely blocked by preabsorbing the polyclonal antiserum with GCAP2-GST 
fusion protein but not GST protein alone (Fig. 20).  
 
 
                                            
 
Figure 20. Detection of GCAP2 in bovine retina can be blocked by GCAP2-GST but not by GST pre-
absorption. The polyclonal GCAP2 antibody specifically detected GCAP2 in a crude retinal extract as a single 
band of the expected molecular weight of approx. 24kDa. This band is specific because it is completely blocked if 
our GCAP2 antiserum was pre-absorbed with its antigen (GCAP2-GST, lane 2) but not by GST alone (lane 3). 
 
 
3.12. RIBEYE INTERACTS WITH GCAP2 BUT NOT WITH GCAP1 
         As described above (Fig.19), the polyclonal GCAP2 antibody raised against 
full-length GCAP2 cross-reacts with GCAP1. Therefore, we analyzed whether 
GCAP1 interacts with RIBEYE in the YTH system. We found that RIBEYE(B) only 
interacts with the carboxyterminal region (CTR) of GCAP2 but not with the CTR of 
GCAP1 (Fig. 21B) indicating that RIBEYE specifically interacts with GCAP2 but not 
with GCAP1. 
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Figure 21A. Schematic depiction of the domain structure of RIBEYE, GCAP2 and GCAP1. GCAP1 and GCAP2 
contain four EF-hands from which the first EF-hand (EF1, colored in yellow) is non-functional. 
 
 
 
 
 
Figure 21B. RIBEYE interacts with GCAP2 but not with GCAP1. 
YTH analyses showed that RIBEYE(B) interacts with the carboxyterminal region (CTR) of GCAP2 but not with 
the CTR of GCAP1. For convenience, experimental bait-prey pairs are underlayered in color (green in case of 
interacting bait-prey pairs; yellow in case of non-interacting bait-prey pairs); control matings are non-colored. The 
hinge 2 region of RIBEYE(B) interacts with the CTR of GCAP2 (mating #6) but not with the CTR of GCAP1 
(matings #1, #7). The respective control matings (auto-activation controls; yeast matings #2-5, #8-9) did not show 
growth on -ALWH selective plates and expression of -galactosidase activity. Mating #10 is an interaction 
positive control. RE(B)856-891 encodes for the hinge 2 region of RIBEYE(B) which was shown to be responsible 
for interaction with GCAP2 (Fig. 3C,D). Abbreviations: CTR, carboxyterminal region; EF1-EF4, EF-hand 1 - EF-
hand 4. 
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3.13. Monoclonal GCAP2 antibody is specific for GCAP2 
Since our polyclonal antibody against GCAP2 cross-reacts with GCAP1,we 
further tested whether commercially available monoclonal antibody against GCAP2 
can cross-reactivity with GCAP1 but it reacts with bovine GCAP2 but not cross-react 
with bovine GCAP1(Fig. 22).  
 
           
 Figure 22. The monoclonal GCAP2 antibody is specific for GCAP2 and does not react with GCAP1. This 
monoclonal antibody detects GCAP2-GST (lane 5), but not GST alone (lane 6), GCAP1-MBP (lane 7) or MBP 
alone (lane 8). The monoclonal GCAP2 antibody specifically detects GCAP2 in purified synaptic ribbons (lane 1, 
Fig.14Ba) and in crude bovine retina extracts (lane 3, Fig.14Ba). the same blot as in Fig. 13Ba as shown after 
stripping and reprobing the blot with a mixture of anti-GST/anti-MBP antibodies to document the loading of 
fusion proteins.  
 
3.14. RIBEYE and GCAP2 can be co-immunoprecipitated from the bovine 
retina 
         To analyse whether this interaction also occurs in vivo, we performed co-
immunoprecipitation experiments using extracts from bovine retina. In fact, GCAP2 
immune serum co-immunoprecipitated RIBEYE (Fig. 23A) whereas GCAP2 pre-
immune serum did not demonstrating the specificity of the experiments. Identical 
results where obtained when RIBEYE antibodies were used for immunoprecipitation. 
RIBEYE immune serum but not RIBEYE pre-immune serum specifically co-
immunoprecipitated GCAP2 (Fig. 23B).  
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Figure 23. Co-immunprecipitation of RIBEYE and GCAP2 from the bovine retina. In A) GCAP2 immune 
serum and GCAP2 pre-immune serum were tested for their capability to co-immunoprecipitate RIBEYE. RIBEYE 
is co-immunoprecipitated by GCAP2 immune serum (lane 2, Fig. 23Aa) but not by GCAP2 pre-immune serum 
(lane 1, Fig. 23Aa). Fig. 23Ab) shows the same blot as in Fig. 23Aa but reprobed with rabbit polyclonal anti-
GCAP2 antibodies. This blot shows the presence of GCAP2 precipitated by the GCAP2 immune serum (lane 2) 
but not by the pre-immune serum (lane 1). Asterisks indicate the immunoglobulin heavy chains. In B) RIBEYE 
immune serum and RIBEYE pre-immune serum were tested for their capability to co-immunoprecipitate GCAP2. 
GCAP2 is co-immunoprecipitated by RIBEYE immune serum (lane 2, Fig 23Ba) but not by RIBEYE pre-immune 
serum (lane 1, Fig. 23Ba). Fig. 23Bb) shows the same blot as in Fig. 15Ba but reprobed with polyclonal anti-
RIBEYE (U2656). This blot shows the presence of RIBEYE that was immunoprecipitated by the immune serum 
but not by the pre-immune serum. Asterisks indicate the immunoglobulin heavy chains. Fig. 23Bc) shows the 
same blot as in Fig. 15Bb but reprobed with mouse monoclonal anti-CtBP2 antibodies which detects the B-domain 
of RIBEYE. This blot also shows the presence of RIBEYE precipitated by the immune serum (lane 2) but not by 
the pre-immune serum (lane 1). Asterisks indicate the immunoglobulin heavy chains. In addition to RIBEYE, a 
further protein at approx 50kDa is present in the experimental precipitate but not in the control immunoprecipitate. 
This band very likely is CtBP2 (circle in lane 2; Fig. 23Bc). CtBP2 is absent from purified synaptic ribbons which 
contain RIBEYE and CtBP1 but not CtBP2 (Schwarz et al., unpublished data). In the input lanes, 0.5% of total 
input was loaded in (A) and 1% of total input in (B). The immunoprecipitates are always 100%. 
 
The co-immunoprecipitation experiments prove that the RIBEYE/GCAP2 interaction 
also occurs in-situ in the retina and emphasizes the physiological relevance of the 
RIBEYE/GCAP2 interaction. This assumption is further supported by our findings 
that GCAP2 is also a component of purified synaptic ribbons as shown both with a 
polyclonal as well as with the monoclonal GCAP2 antibody (Fig. 23A,B). 
 
 
 
 
 
A B 
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3.15. GCAP2 present in purified synaptic ribbons 
          RIBEYE is a major component of synaptic ribbons (Schmitz et al., 2000; 
Zenisek et al., 2004; Wan et al. 2005, Magupalli et al., 2008). Therefore it is 
important to know whether GCAP2 present in purified synaptic ribbons. We used 
both GCAP2  polyclonal (rabbit) and monoclonal (mouse) antibodies to answer this 
question.The polyclonal GCAP2 antiserum detects GCAP2 both in extracts of the 
bovine retina (lane 2) as well as in the purified synaptic ribbon fraction (lane 1) 
(100g of protein loaded in each lane) (Fig. 24A). Similar to the findings obtained 
with the polyclonal GCAP2 antibody, the monoclonal GCAP2 antibody also detects 
GCAP2 in both retinal extracts (lane 1, 100g of protein loaded) and purified 
synaptic ribbon fraction (lane 2, 30g of protein loaded) (Fig. 24B).  
                                          
 
Figure  24. GCAP2 is present on purified synaptic ribbons.  
(A) The polyclonal GCAP2 antiserum detects GCAP2 both in extracts of the bovine retina (lane 2) as well as in 
the purified synaptic ribbon fraction (lane 1) (100µg of loaded protein in each lane). (B)The monoclonal GCAP2 
antibody detects GCAP2 both in retinal extracts (lane 1, 100µg of protein loaded) as well as in the purified 
synaptic ribbon fraction (lane 2, 30µg of protein loaded). 
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3.16. GCAP2 co-localizes with synaptic ribbons in photoreceptor ribbon 
synapses 
 We performed immunolabeling experiments with a polyclonal GCAP2 
antibody raised against bacterially expressed and purified full-length bovine GCAP2  
as well as with the commercial monoclonal mouse GCAP2 antibody (Fig. 25A-F).  
        
Figure  25. GCAP2 co-localizes with synaptic ribbons in photoreceptor ribbon synapses.  
Immunolabeling of the bovine retina with rabbit polyclonal antibodies against GCAP2 and mouse monoclonal 
antibodies against RIBEYE(B)/CtBP2 (A-C) or mouse monoclonal antibodies against GCAP2 (A1, Santa Cruz) 
and rabbit polyclonal antibodies against RIBEYE (U2656) (D,E). Both the polyclonal (A-C) as well as the 
monoclonal (D) GCAP2 antibody generated a strong immunolabel particularly in the inner segments (IS) of 
bovine photoreceptor cells. In addition, the OPL that contains photoreceptor ribbon synapses is strongly labeled by 
the polyclonal (A-C) and monoclonal GCAP2 antibodies (D-E). The OPL which is immunolabeled by the GCAP2 
antibodies is labelled by arrows in (A,B). The GCAP2 immunosignal co-localized with synaptic ribbons which 
were visualized by immunolabeling with RIBEYE antibodies (B-E, arrows). Strong immunosignals of GCAP2 
were found at synaptic ribbons and in close vicinity to synaptic ribbons. Most, but not all ribbons, co-localize with 
GCAP2. The arrowhead in (C) denotes synaptic ribbons which were not associated with detectable amounts of 
GCAP2. (F) The GCAP2 immunosignal in the outer plexiform layer (OPL) largely co-localizes with the 
immunosignal of synaptophysin, a marker protein of synaptic vesicles highly enriched in the presynaptic terminals 
(arrow in F). Abbreviations: OS, outer segment; IS, inner segment; ONL, outer nuclear layer; OPL, outer 
plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer. Scale bar: 15µm (A,B,D); 10µm (C,E,F). 
In collaboration with Sivaraman Natarajan  
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we observed a strong GCAP2 immunolabeling in the synaptic terminals of bovine 
photoreceptors in addition to a strong expression particularly in the inner segments 
(Fig. 25A-F). A strong immunolabeling of the rod presynaptic terminals was 
observed, the labeling of the larger cone terminals was less intense. Double 
immunolabeling demonstrated that RIBEYE and GCAP2 co-localized in the 
presynaptic terminals of photoreceptors (Fig. 25B-E). In Fig. 25F presynaptic 
terminals were labelled with antibody against Synaptophysin. GCAP2 was found at 
synaptic ribbon sites (immunolabeled by RIBEYE antibodies) and close to synaptic 
ribbons. Most but not all ribbons were labelled (Fig. 25). Furthermore, identical 
results, as described above for the polyclonal GCAP2 antibody, were obtained with a 
commercially available monoclonal antibody against GCAP2 (Fig. 25D-E).that does 
not cross-react with GCAP1 (Fig. 22).  
 
3.17. GCAP2 is weakly expressed in cone photoreceptor ribbon synapses 
         The bovine retina is a mixed retina that contains both rod and cone 
photoreceptors. As already shown in Fig. 25 GCAP2 is strongly expressed in rod 
photoreceptor synapses where it co-localizes with synaptic ribbons (immunolabeled 
with RIBEYE antibodies). Rod synapses only contain a single synaptic ribbon in their 
active zone (Schmitz et al., 1996, 2000). The cone synapses (arrows) only show a 
weak GCAP2 immunoreactivity. Cone synapses can be readily identified in these 
sections and discriminated from rod synapses based on their typical localization 
closer to the inner nuclear layer (INL), their large size and the presence of numerous 
synaptic ribbons (Schmitz et al., 1996; 2000). In (Fig. 26C,D) cone synapses were 
visualized with polyclonal antibodies against SV2A which is only expressed in cone 
synapses but not in rod synapses (Wang et al., 2003; Morgans et al., 2009); GCAP2 
was immunodetected with monoclonal GCAP2 antibody in (Fig. 26C,D). In (Fig. 
26E) cone synapses were identified with fluorescently labelled peanut agglutinin 
(PNA) (Wang et al., 2003; Morgans et al., 2009). In these incubations, the GCAP2 
immunosignal neither co-localized with SV2A (Fig. 26C,D) nor with PNA (Fig. 26E) 
further demonstrating that GCAP2 is not or weakly expressed in cone photoreceptor 
synapses. 
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Figure  26. GCAP2 is weakly expressed in cone photoreceptor ribbon synapses.  
Cryostat sections of the bovine retina immunolabeled with rabbit polyclonal antibodies against GCAP2 and 
monoclonal antibodies against RIBEYE(B)/CtBP2 (BD Transduction Laboratories) (A,B). In (C,D) cone synapses 
were visualized with polyclonal antibodies against SV2A which is only expressed in cone synapses but not in rod 
synapses (Wang et al., 2003; Morgans et al., 2009); GCAP2 was immunodetected with monoclonal GCAP2 
antibody in (C,D). In (E) cone synapses were identified with fluorescently labelled peanut agglutinin (PNA) 
(Wang et al., 2003; Morgans et al., 2009). In these incubations, the GCAP2 immunosignal neither co-localized 
with SV2A (C,D) nor with PNA (E) further demonstrating that GCAP2 is not or weakly expressed in cone 
photoreceptor synapses. Abbreviations: ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear 
layer. Scale bars: 10µm. 
Contributed by Sivaraman Natarajan 
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3.18. Labeling of presynaptic GCAP2 immunosignals can be blocked by pre-
absorption with GCAP2-GST but not by GST . 
GCAP2 was found at synaptic ribbon sites (immunolabeled by RIBEYE 
antibodies) and close to synaptic ribbons (Fig. 26). Most but not all ribbons were 
labeled (Fig. 26).    
                                                                              
Figure  27. Labeling of presynaptic GCAP2 immunosignals can be blocked by GCAP2-GST but not by GST 
pre-absorption. Cryostat sections immunolabeled with polyclonal anti-GCAP2 antiserum pre-absorbed with GST 
(A,B,E,F) or GCAP2-GST (C,D,G,H). (A-D) The GCAP2 immunolabeling in the OPL, as well as in the IS and 
OS cannot be blocked by pre-absorption with GST (A) but by pre-absorption with GCAP2-GST (C). After pre-
absorption of the GCAP2 polyclonal antiserum the GCAP2 immunosignal is gone (C) whereas after pre-
absorption with GST the GCAP2 immunosignal remained unchanged (A). (B,D) represent the respective phase 
pictures for (A,C). (E,F) Pre-absorption of GCAP2 antiserum with GST does not influence the GCAP2- as well as 
the RIBEYE- immunosignal in ribbon synapses of the OPL and IPL. In contrast, pre-absorption of the GCAP2 
antiserum with GCAP2-GST (G,H) abolishes GCAP2 immunosignals but not the RIBEYE immunosignals 
demonstrating the specificity of the GCAP2 pre-absorption. (E,G) are low magnification micrographs from the 
indicated immunolabelings (F,H) are high magnification micrographs from the indicated immunolabelings. 
Abbreviations: OS, outer segment; IS, inner segment; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, 
inner nuclear layer; IPL, inner plexiform layer. Scale bars: 10 µm (A-D, F,H); 30 µm (E, G). 
Contributed by Sivaraman Natarajan 
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The GCAP2 immunosignals were specific because the signal could be completely 
blocked by preabsorbing the polyclonal antiserum with GCAP2-GST fusion protein 
but not GST protein alone (Fig. 27) polyclonal anti-GCAP2 antiserum pre-absorbed 
with GST (A,B,E,F) or GCAP2-GST (C,D,G,H). The GCAP2 immunolabeling in the 
OPL, as well as in the IS and OS cannot be blocked by pre-absorption with GST (A) 
but by pre-absorption with GCAP2-GST (C). After pre-absorption of the GCAP2 
polyclonal antiserum the GCAP2 immunosignal is gone (C) whereas after pre-
absorption with GST the GCAP2 immunosignal remained unchanged (A). Pre-
absorption of GCAP2 antiserum with GST (E,F) does not influence the GCAP2- as 
well as the RIBEYE- immunosignal in ribbon synapses of the OPL and IPL. In 
contrast, pre-absorption of the GCAP2 antiserum with GCAP2-GST (G,H) abolishes 
GCAP2 immunosignals but not the RIBEYE immunosignals demonstrating the 
specificity of the GCAP2 pre-absorption.      
 
 3.19. RIBEYE and GCAP2 are localized very close to each other in 
photoreceptor synapses as judged by in-situ Proximity Ligation Assays (PLA). 
The close association of RIBEYE and GCAP2 in-situ was further supported 
by in-situ Proximity Ligation Assays (PLA assays; Gustafsdottir et al., 2005) on 
flash-frozen mouse retinal sections (Fig. 28). PLA in-situ interaction assays critically 
depend on the close proximity of the interaction partners (Söderberg et al., 2006). In 
PLA assays, the secondary antibodies are labeled with specific oligonucleotides. Only 
if the two antigens detected by two different primary antibodies are in close proximity 
to each other (less than 40nm), a linker oligonucleotide can hybridize to the distinct 
PLUS/MINUS oligonucleotides conjugated to the secondary antibodies and provide 
the template for a rolling circle amplification (Söderberg et al., 2006, 2008). The 
product of the rolling circle amplification is then specifically detected by a 
fluorescent oligonucleotide probe (Fig. 28). In case of RIBEYE and GCAP2 a strong 
PLA interaction signal was observed in the OPL (Fig. 28A-E).  
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Figure 28. Co-localization of RIBEYE and GCAP2 as analyzed by In-situ Proximity Ligation Assays (PLA). 
Co-localization of RIBEYE and GCAP2 in retinal sections in-situ was analyzed using proximity ligation assays 
(Gustafsdottir et al., 2005; Söderberg et al., 2008). This assay critically depends upon the distance of the 
interaction partners and a positive PLA interaction signal is only generated if the interaction partners are located in 
a distance of less than 40nm (Söderberg et al., 2006). A strong PLA interaction signal in the OPL, as visualized by 
the red fluorescence signal, was observed between RIBEYE and GCAP2 (Fig. 28A-E). In Fig. 28A,B an overview 
of the PLA signals is given at a low magnification. Fig. 28C-E are high magnifications of the OPL. In Fig. 28B 
and in Fig. 28E the PLA signals of Fig. 28A and Fig. 28D is superimposed onto the respective phase images. 
Arrows point to PLA interaction signals in the OPL indicating close proximity of RIBEYE and GCAP2. No PLA 
interaction signal was present in the OPL if both primary antibodies were omitted (Fig. 28F,G) or if only one 
primary antibody was applied (Fig. 28H,I) demonstrating the specificity of the detection assay. In Fig. 28G the 
PLA signal of Fig. 19F is superimposed onto the respective phase image. As a further negative control RIBEYE 
and opsin were tested for interaction by PLA and did not produce any signal in the OPL (Fig. 28J) again 
demonstrating specificity of the PLA interaction assays. In contrast, a mixture of RIBEYE (U2656)/CtBP2 
antibodies (positive control) gave a strong PLA interaction signal in the OPL (Fig. 28L). A mixture of 
GCAP2/opsin antibodies generated a strong PLA interaction signal in the outer/inner segments but not in the OPL 
(Fig. 28K). RIBEYE and mGluR6 which are located relatively closely together but beyond the critical distance of 
PLA assays of ~40nm (Söderberg et al., 2006) did not produce a PLA interaction signal in the OPL (Fig. 28M) 
demonstrating that PLA interaction signals clearly indicate very close proximity of the analyzed antigens. The 
arrows in K and L point to PLA interaction signals. Abbreviations: IS, inner segments; ON, outer nuclear layer; 
OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer. Scale bars: 10µm (A-J). 
Contributed by Sivaraman Natarajan 
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There was no interaction signal present in the OPL if both primary antibodies were 
omitted or if only one primary antibody was applied (followed by incubation with the 
two oligonucleotide-conjugated secondary antibodies) demonstrating the specificity 
of the detection assay. As a further negative control RIBEYE and opsin were tested 
for interaction by PLA and did not produce any signal in the OPL further 
demonstrating specificity of the PLA interaction assays (Fig. 28J). In contrast, a 
mixture of rabbit polyclonal RIBEYE (U2656) and mouse monoclonal CtBP2 
antibodies (positive control) gave a strong PLA interaction system in the OPL (Fig. 
28L). Remarkably, RIBEYE and mGluR6 did not produce a PLA interaction signal in 
the OPL (Fig. 28M). RIBEYE at the synaptic ribbon and mGluR6 at the tips of 
invaginating ON bipolar cells of the ribbon synapse obviously are not close enough to 
produce a PLA interaction signal further emphasizing the very close proximity of 
GCAP2 and synaptic ribbons in the presynaptic terminal in-situ (see discussion).  
 
3.20. Characterization of RIBEYE(B)-GCAP2 binding 
 
In order to further characterize binding of GCAP2 to RIBEYE we analyzed 
why the presence of 1mM ME is essential for RIBEYE-GCAP2 interaction in the 
fusion protein pull-down experiments. If ME was absent from the incubation buffer, 
RIBEYE(B) did not bind to GCAP2-GST in the fusion protein pull-down assays (Fig. 
17A; Fig. 30A,B). It is well known that ME can cleave disulfide bridges (for review, 
see Berg et al., 2007). rRIBEYE(B)-domain contains 8 cysteine residues: 
RIBEYE(B)C587; RIBEYE(B)C603; RIBEYE(B)C667; RIBEYE(B)C683; 
RIBEYE(B)C781; RIBEYE(B)C786; RIBEYE(B)C861 and RIBEYE(B)C899. From 
these cysteines only cysteine C667 and cysteine C899 in the SBD of RIBEYE are 
predicted to be close enough to form disulfide bridges in monomeric RIBEYE (Fig. 
29A,B). RIBEYE(B)C667 is located in SBDa spatially close to RIBEYE(B)899C in 
the SBDb and a disulfide bridge between these residues would thus link the two 
different parts of the SBD with each other. We analyzed RIBEYE(B)C899S for its 
capability to interact with GCAP2 and tested whether this RIBEYE point mutant 
needs ME to interact with GCAP2 in pull-down assays. Most interestingly, 
RIBEYE(B)C899S interacted with GCAP2 in the absence of ME (Fig. 30B) 
demonstrating that RIBEYE(B)C899S does not need ME to bind to GCAP2. 
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Figure 29. (A) Localization of cysteine residues in RIBEYE(B): Only cysteine C667 and cysteine C899 are 
located within a distance of ~4Å to form a disulfide bridge. (B) A predicted disulfide bridge between C667 in 
SBDa and C889 in SBDb (indicated by a yellow-black dashed line) can be expected to limit the rotational freedom 
of the hinge 2 region and the movement of the SBDb relative to SBDa. The structure model in (A,B) starts at 
amino acid P575 and ends at amino acid F905 of RIBEYE and is based on the crystal structure of tCtBP1 (Kumar 
et al., 2002; Nardini et al., 2003; see also Magupalli et al., 2008; Alpadi et al., 2008). 
 
 
Figure 30. The binding of GCAP2 to the hinge 2 region of RIBEYE(B) is modulated by the substrate-
binding subdomain (SBD) of RIBEYE(B). (A, B) Fusion protein pull-down assays analyzed by SDS-PAGE 
(10% acrylamide gels). (A) GCAP2 does not pull-down both wild type RE(B) as well as RE(B)C683S in the 
absence ME (lanes 8,10) but only in the presence of ME (lanes 7,9; arrowheads). (B) In contrast, GCAP2 pulls 
down RIBEYE(B)C899S in the absence of ME lane 8 (arrowhead). 
 
The binding of RIBEYE(B)C899S to GCAP2 in the absence of ME indicates that 
cysteine C899 is part of the “-mercaptoethanol effect” that promotes 
GCAP2/RIBEYE interaction. Mutating RIBEYE(B)C683 (which is located in the 
homo-dimerization interface of the NBD (Fig. 30A) into RIBEYE(B)C683S did not 
change the dependency of GCAP2/RIBEYE binding from the presence of ME (Fig. 
A B  
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30A, lane 7-8). RIBEYE(B)C683S did not interact with GCAP2 in the absence of 
ME (Fig. 30A, lane 8) demonstrating that only specific cysteine mutations of 
RIBEYE(B) lead to an independence from ME for GCAP2 binding. 
RIBEYE(B)C899S which was shown to be important in modulating 
GCAP2/RIBEYE interaction (Fig. 30B, Fig. 29A,B) is located in the SBD of 
RIBEYE(B). 
 
3.21. Mutations in SBD of RIBEYE influence the binding of GCAP2 to 
RIBEYE(B) 
I also tested non-cysteine mutants of the SBD, namely RIBEYE(B)F904W 
and RIBEYE(B)CTR, for their capability to interact with GCAP2. RIBEYE(B)F904 
is located in the SBDb at the end of the modelled structure (Fig. 9B; Fig. 10A,B; Fig. 
29A,B). RIBEYE(B)CTR lacks the hydrophobic carboxyterminal region (CTR; 
aa912-918 of RIBEYE); the structure of the CTR has not yet been resolved (Kumar et 
al., 2002; Nardini et al., 2003). RIBEYE(B)F904W and RIBEYE(B)CTR did not 
interact with GCAP2 in the YTH system although these mutants are not within the 
proper binding region of RIBEYE for GCAP2 (Fig. 29A,B). We interpret these data 
that the latter mutants of the SBD are likely not relevant for a direct physical 
interaction with GCAP2 but are less well capable to stabilize a conformation of the 
hinge 2 region that can bind GCAP2. 
 
Figure 31. Mutations in SBD of RIBEYE influence the binding of GCAP2 to RIBEYE(B): Point mutating 
F904 in RIBEYE(B) to RE(B)F904W abolishes RIBEYE(B)-GCAP2 interaction in the YTH system (mating #1). 
Similarly, deleting the hydrophobic carboxyterminal region (CTR) of RIBEYE(B) results in a lack of interaction 
between RIBEYE and GCAP2 in the YTH system (mating #7). 
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3.22. RIBEYE(B)-GCAP2 interaction is NAD(H)-dependent 
I tested whether the reducing power of ME is important in promoting 
RIBEYE-GCAP2 interaction. RIBEYE(B) efficiently binds reduced NAD(H) 
(Schmitz et al., 2000; Alpadi et al., 2008) Therefore, we analyzed whether NADH 
could replace ME in promoting RIBEYE-GCAP2 interaction. Indeed, GCAP2 
bound to RIBEYE(B) in the absence of ME if NADH was present in the incubation 
buffer (Fig. 32A,B). Surprisingly, also the oxidized form of NAD(H), NAD+, induced 
RIBEYE(B)-GCAP2 interaction in the absence of ME (Fig. 32B) demonstrating that 
the reducing power of NADH does not play a major role in promoting GCAP2-
RIBEYE interaction. Both the oxidized as well as the reduced form of NAD(H) 
(NAD+ and NADH, respectively) stimulate RIBEYE-GCAP2 interaction.  
 
 
Figure 32. NADH and NAD+ are essential co-factors for the binding between RIBEYE and GCAP2 in the 
absence of -mercaptoethanol (-ME). Fusion protein pull-down assays were analyzed by SDS-PAGE (10% 
acrylamide gels). RIBEYE(B) binds NAD(H) with high affinity (Schmitz et al., 2000). (A,B) In fusion protein 
pull-down assays, GCAP2-RIBEYE(B) interaction requires the presence of -mercaptoethanol (-ME). If ME is 
absent GCAP2 does not bind to RIBEYE(B) unless NADH or NAD+ is added to the incubation buffer. Both the 
reduced form (NADH) (Fig. 22A) as well as the oxidized form (NAD+) (Fig. 22B) promote RIBEYE(B)-GCAP2 
interaction. 
 
3.23. Low concentrations of NAD(H) promote RIBEYE/GCAP2 interaction 
         In the fusion protein pull-down analyses the fusion proteins were used at an 
equimolar concentration of 0.8µM. We tested whether low concentrations of NAD+ 
(A) or NADH (B) (ranging from 0.1 to 0.8µM) were able to stimulate binding of 
RIBEYE to GCAP2. Even the lowest concentration of NAD+ or NADH (0.1µM) 
stimulated binding of RIBEYE(B)-MBP to GCAP2-GST (lanes 3-6); without 
addition of NAD+ or NADH no binding was observed between GCAP2-GST and 
RE(B)-MBP in the absence of ME (lane 1). The addition of ME replaced the need 
for either NAD+ or NADH in promoting GCAP2-RIBEYE(B) interaction: even in the 
B A 
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absence of NAD+/NADH GCAP2 bound to RIBEYE(B) if ME was present (lane 2). 
In (C) and (D) even lower concentrations of NAD+ (C) or NADH (D) were tested. 
NAD+/NADH promoted RIBEYE(B)/GCAP2 binding already at concentrations as 
low as 10nM (lane 4). If still lower concentrations of NAD(H) were used, i.e. 1nM 
and 5nM (lanes 2,3) interaction was no longer observed, similar to the absence of 
interaction in the absence of any NAD+ (lane 1;  Fig. 33C)/ or NADH (lane 1; Fig. 
33D). The incubation buffer in the experiments shown in Fig. 33C,D did not contain 
any ME. 
 
Figure  33. Low concentrations of NAD(H) promote RIBEYE/GCAP2 interaction. 
The binding of RIBEYE(B)-MBP (0.8µM) to GST-GCAP2 (0.8 µM) was analyzed in the presence of increasing 
concentrations of NAD+ (A,C) or NADH (B,D). In A and B  we tested low concentration of NAD+ and NADH 
ranging from 0.1µM to 0.8µM  (lane3 to lane6) were stimulating  binding of RE(B)MBP  to GCAP2-GST. In C 
and D we tested even lower concentration of NAD+ and NADH ranging from 1nM to 100nM. At the 
concentration of 10nM (lane4) both NAD+ and NADH promotes GCAP2/RIBEYE(B) binding but if  we used 
lower  concentration i.e., 1nM and 5nM  of NAD+ and NADH interaction was no longer observed (lane 2,3). 
 
 
 
 
 
 
A C 
D B 
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3.24. NAD(H) binding-deficient RIBEYE(B)G730A mutant 
I analyzed the NAD(H)-binding-deficient RIBEYE point mutant, 
RIBEYE(B)G730A, (Magupalli et al., 2008; Alpadi et al., 2008) in the YTH system 
for interaction with GCAP2. In agreement with the essential requirement of NAD(H) 
in promoting RIBEYE/GCAP2 interaction in fusion protein pull-down analyses, 
GCAP2 did not interact with this NAD(H) binding-deficient RIBEYE point mutant in 
the YTH system (Fig. 34) although this RIBEYE point mutant was able to efficiently 
hetero-dimerize with RIBEYE(B) wildtype protein . 
 
Figure 34. NAD(H) binding-deficient RIBEYE(B)G730A mutant. GCAP2 did not bind to the NAD(H)-
binding-deficient RIBEYE point mutant RIBEYE(B)G730A in the YTH system as judged by the lack of growth 
on –ALWH selective medium and lack of -galactosidase expression (mating #2). Mating #1 indicates a positive 
control (RIBEYE(B) mated with GCAP2). Matings #3-6 show the respective auto-activation controls. 
RIBEYE(B)G730A is still able to homo-dimerize with wildtype RIBEYE(B) demonstrating that 
RIBEYE(B)G730A is not misfolded (mating #7). For convenience, experimental bait-prey pairs are underlayered 
in color (green in case of interacting bait-prey pairs; yellow in case of non-interacting bait-prey pairs); control 
matings are non-colored. 
 
3.25. Viral overexpression of GCAP2 in presynaptic photoreceptor terminals 
promotes disassembly of photoreceptor synaptic ribbons. 
            We further tested whether synaptic GCAP2 expression could be related to the 
Ca2+-dependent dynamic changes of synaptic ribbons. For this purpose, we generated 
recombinant GCAP2-EGFP expressing Semliki Forest (SLF) virus and used this 
recombinant virus for infecting retinal explants. EGFP-expressing SLF virus served 
as control virus. In organotypic retinal explant cultures the recombinant SLF viruses 
preferentially infected photoreceptors (Fig. 35A-D). Photoreceptors were infected at a 
high density with the SLF viruses (Fig. 35A,B) and showed expression of GCAP2-
EGFP (Fig. 35C) or EGFP (Fig. 35D) throughout all photoreceptor cell compartments 
including the synaptic terminals (Fig. 35). Our organotypical cultures did no longer 
contain outer segments as also observed in other organotypic retinal cultures. 
Interestingly, photoreceptor terminals that were infected with GCAP2-EGFP virus 
typically displayed a loss of synaptic ribbons as analyzed by co-immunolabeling with 
RIBEYE antibodies (U2656) (Fig. 35E-L, Fig. 35R). Photoreceptor terminals infected 
with EGFP-virus (control virus) did not show loss of synaptic ribbons indicating that 
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the loss of synaptic ribbons in GCAP2-EGFP-infected photoreceptors is not due to a 
cytopathic effect of the virus infection itself (Fig. 35M-R).  
 
Figure 35. Overexpression of GCAP in photoreceptor terminals disassembles synaptic ribbons 
Recombinant expression of either GCAP2-EGFP or EGFP in organotypic retina explant cultures (A-D). Simliki 
Forest (SLF) virus efficiently infects photoreceptors in organotypical explant cultures of the retina. SLF-mediated 
GCAP2-EGFP (A-C) heterologous expression labels the entire photoreceptor from the inner segments to the 
synaptic terminals (arrows) in the OPL. As generally observed by us and other groups, outer segments are absent 
from explant preparations. In analogy to GCAP2-EGFP expression also infection with EGFP-SLF virus leads to 
labelling of the entire photoreceptor (D) in retina explant culture. Scale bars in A-D represent 10µm. (E-Q) Three-
dimensional reconstructions of individual optical stacks along the z-axis of SLF virus infected retina explant 
recorded with the apotome (Zeiss). (E-Q) In order to visualize synaptic ribbons in GCAP2-EGFP- and EGFP-
infected retina explants, samples were immunolabeled with polyclonal RIBEYE antibody (U2656, red signals). 
Synaptic ribbons are abundantly present in the OPL of the organotypical retina cultures but absent from GCAP2-
EGFP-expressing photoreceptor terminals (white arrows in E-I, asterisks in J-Q). (E-I) show lower 
magnifications of a three-dimensional reconstructed GCAP2-EGFP expressing photoreceptor from different 
angles to emphasise the lack of synaptic ribbons within the terminal (white arrows) without influencing the 
presence of synaptic ribbons (arrowhead in E) in the neighboring non-infected photoreceptors. The x,y and z 
labeled arrows indicate the coordinate axes in the three dimensions and are scaled to represent the distance of 5 
µm in each spacial direction. (J-L) represent high magnifications of GCAP2-EGFP infected photoreceptor 
terminals. Although abundant ribbon labeling (red signals) can be detected next to the infected terminals 
(asterisks) no ribbon structures are present within the GCAP2 overexpressing terminals. (M-Q) Lack of ribbon 
structures within infected photoreceptor terminals is not due to viral infection as terminals overexpressing EGFP 
alone do contain ribbon structures (M-Q) visualized by the yellow color within the EGFP expressing synaptic 
terminals. (N) and (O) represent view of the same infected, EGFP-expressing terminal as in (M) but from different 
angles. (R) Statistical analysis of photoreceptor terminals infected with either EGFP-SLF virus or GCAP2-EGFP-
SLF-virus. In contrast to EGFP overexpressing photoreceptor terminals 70% of synaptic terminals overexpressing 
GCAP2 lack synaptic ribbons. Error bars represent standard deviation, numbers in parentesis indicate the number 
of counted terminals per construct. Abbreviations: OS, outer segments; IS, inner segments; ONL, outer nuclear 
layer; OPL, outer plexiform layer. 
Contributed by Karin Schwarz and Sivaraman Natarajan 
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The same observation described above for the light microscopic analyses was also 
observed at the electron microscopic level using EM analyses of GCAP2-EGFP and 
EGFP (control)-infected retinas (Fig. 36). In GCAP2-EGFP-infected retinas we 
observed a dramatic reduction in the number of synaptic ribbons in comparison to 
EGFP-infected control retinas. 
 
 
 
 
Figure 36. Overexpression of GCAP2 in photoreceptor terminals disassembles synaptic ribbons: Electron 
microscopic analyses. Recombinant expression of either GCAP2-EGFP (A-G) or EGFP in organotypic retina 
explant cultures (H-L), see also Fig. 35. Infection with GCAP-EGFP (A-G) leads to a loss of synaptic ribbons at 
the presynaptic active zones (labelled by arrows). In many cases, instead of bar-shaped anchored synaptic ribbons, 
floating, non-anchored spherical synaptic ribbons (ss) were observed which are considered as intermediate stages 
in the disassembly of synaptic ribbons. EGFP-transfected photoreceptors (control infections; H-L) displayed 
normally looking photoreceptor terminals with normal looking bar-shaped synaptic ribbons. M: semiquantitative 
evaluation: Approximately 180 randomly picked synapses were analyzed for the presence of bar-shaped synaptic 
ribbons (>150nm in length) at photoreceptor active zones (6 retinas for each construct). GCAP2-EGFP infected 
retinas show a dramatic reduction of bar-shaped synaptic ribbons in comparison to EGFP (control)-infected 
retinas. Abbreviations: pr, presynaptic terminal; po, postsynaptic dendrites; sr, synaptic ribbon; ss, spherical 
synaptic ribbon (synaptic sphere); m, mitochondrion. Scale bars: 1µm (A,B,D,E); 250nm (C), 500nm (F,G-L). 
Contributed by Karin Schwarz and Sivaraman Natarajan 
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GCAP2 is a photoreceptor-enriched neuronal Ca2+-sensor protein. Its role as a 
Ca2+-dependent modulator of the phototransduction cascade is well known (for 
review, see Palczewski et al., 2004). Previous studies have shown that GCAP2 is not 
restricted to photoreceptor outer and inner segments but also present in photoreceptor 
presynaptic terminals (Otto-Bruc et al., 1997; Duda et al., 2002, Pennesi et al., 2003; 
Makino et al., 2008). The function of GCAP2 in photoreceptor synapses is not 
known. The analyses of GCAP2 knockout mice suggested a synaptic function of 
GCAPs based on ERG analyses that showed a defect in the b-wave of the 
electroretinogram (Pennesi et al., 2003). But the mechanism how GCAPs might work 
in the synapse remained unclear. In the present study, we provide first evidence how 
GCAP2 works in the synapse. We showed with many different, independent 
approaches that RIBEYE, the major component of synaptic ribbons in the active zone 
of photoreceptor synapses, binds to GCAP2.  
 
4.1. RIBEYE-GCAP2 interaction requires structural rearrangements of 
RIBEYE(B)-domain 
The hinge 2 region of RIBEYE(B) is responsible for the interaction with the 
carboxyterminal region of GCAP2 as shown by YTH analyses. This suggestion is 
further supported by the analysis of point mutants of the hinge 2 region that 
completely abolished RIBEYE-GCAP2 interaction. Therefore, the hinge 2 region of 
RIBEYE(B) represents the core docking region for GCAP2. The hinge 2 region 
serves as a flexible linker and its conformation is dependent on NAD(H) binding as 
judged by structural analyses obtained for members of D-isomer-specific hydroxyacid 
dehydrogenase family to which also RIBEYE belongs (Lamzin et al., 1994; Goldberg 
et al., 1994, Kumar et al., 2002, Nardini et al., 2003; for review, see Popov and 
Lamzin, 1994, Chinnadurai, 2002). NAD(H) binding results in a significant change in 
the overall conformation of the entire protein. NAD(H)-binding induces movement of 
the SBD towards to the NBD via rotation around the hinge regions (Lamzin et al., 
1994) resulting in closure of the NAD(H) binding cleft (“closed” conformation). 
Additionally, binding of NAD(H) results in the structural organization of the 
carboxyterminal region (CTR) (Lamzin et al., 1994). The NAD(H)-induced creation 
of a new -helix that interacts with NADH stabilizes the “closed” conformation 
(Lamzin et al., 1994). This event was shown for formate dehydrogenase (Lamzin et 
al., 1994) from which structures exist in both the apo- and holo-state. Since 
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RIBEYE(B) belongs into the same protein family, it is reasonable to assume similar 
structural changes also in RIBEYE(B) in response to NAD(H) binding (Lamzin et al, 
1994; Goldberg et al., 1994; Kumar et al., 2002; Nardini et al., 2003). 
Thus, we suggest that binding of GCAP2 to the hinge 2 region of RIBEYE(B) 
requires the NAD(H)-induced, closed conformation of RIBEYE(B). This hypothesis 
can explain the NAD(H)-induced stimulation of GCAP2 binding and provides an 
explanation for the observed modulatory role of the SBD: As discussed above, 
formation of the NAD(H)-induced closed conformation requires considerable 
structural rearrangements in the SBD and movement of both SBDa and SBDb. The 
predicted disulfide bridge between C667 and C899 locks SBDa to the SBDb and 
restricts the movements of the two portions of the SBD relative to each other (Fig. 
8E). Therefore, the observed capability of RIBEYE(B)C899S to bind GCAP2 in the 
absence of -ME could be attributed to an enhanced conformational flexibility of the 
SBD. In the cysteine mutant RIBEYE(B)C899S a disulfide bridge can no longer be 
formed between cysteines C667 and C899. We propose that this enhanced structural 
flexibility of the SBD in RE(B)C899S favors a conformation of the flexible hinge 2 
region that is able to bind GCAP2 similar to the NAD(H)-bound conformation. The 
incapability of the RIBEYE(B) mutants RIBEYE(B)F904W and RIBEYE(B)∆CTR 
to bind to GCAP2 can be explained by a decreased capability of these mutants to 
stabilize the closed conformation. RIBEYE(B)∆CTR lacks the hydrophobic 
carboxyterminal region (CTR) of RIBEYE(B) which undergoes enormous structural 
re-arrangements upon NADH binding (Lamzin et al., 1994; Nardini et al., 2003). 
RIBEYE(B)F904 is located at the beginning of the CTR in the SBD of RIBEYE(B) 
(Magupalli et al., 2008). The CTR has an important role in stabilizing the closed 
conformation in the D-isomer-specific 2-hydroxyacid dehydrogenase protein family 
(Lamzin et al., 1994). We suggest that the incapability of the RIBEYE(B)∆CTR 
mutant and of the RIBEYE(B)F904W mutant to bind to GCAP2 is based on the 
insufficient stabilization of the closed conformation. We propose that these mutants 
destabilize a conformation of the hinge 2 region of RIBEYE(B) that is compatible 
with GCAP2 binding. Further investigations will be necessary to understand the 
complex regulation of GCAP2-RIBEYE interaction and how it is mediated by 
structural changes in the protein. 
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4.2. GCAP2, a candidate to mediate Ca2+- and illumination-dependent synaptic 
ribbon dynamics 
RIBEYE is a major component of synaptic ribbons (Schmitz et al., 2000; 
Zenisek et al., 2004; Wan et al. 2005, Magupalli et al., 2008) and therefore synaptic 
ribbons can probably bind considerable amounts of GCAP2. Such a Ca2+-sensing- 
and buffering protein placed in the active zone will shape Ca2+-dependent synaptic 
vesicle trafficking in ribbon synapses (von Gersdorff and Matthews, 1994; Neves and 
Lagnado, 1999; Beutner et al., 2001; Thoreson et al., 2004; Innocenti and 
Heidelberger, 2007). The binding of GCAP2 to RIBEYE is regulated by NAD(H) and 
provides the synaptic ribbon with a dynamically adjustable Ca2+-sensing and Ca2+-
buffering system. The NAD(H)-dependent, dynamic RIBEYE-GCAP2 interaction 
explains why most, but not all, of the synaptic ribbons contain GCAP2 (Figs. 
17,18.19). Since GCAP2 needs to be recruited to synaptic ribbons the physiological 
processes targeted by GCAP2 are likely not extremely fast. More likely, slower Ca2+-
dependent processes will be affected. We propose that GCAP2 mediates the known 
Ca2+-dependent structural changes of synaptic ribbons during light- and darkness. A 
variety of studies have shown that synaptic ribbons (e.g. number and shape of 
synaptic ribbons) are important determinants of synaptic performance that adjust the 
synaptic machinery to transmit a broad range of stimulus intensities (Hull et al., 2006; 
Johnson et al., 2008; Meyer et al., 2009). The structure of synaptic ribbons is 
dynamically regulated. Spiwoks-Becker et al. (2004) demonstrated disassembly of 
synaptic ribbons in photoreceptor terminals during illumination when exocytosis is 
low. Illumination of photoreceptors also reduces the presynaptic Ca2+ concentration in 
photoreceptor ribbon terminals (Jackman et al., 2009). Interestingly, the tendency of 
synaptic ribbons to disassemble during environmental illumination could be 
mimicked by removing (chelating) extracellular Ca2+ indicating that Ca2+ is an 
important mediator of synaptic ribbon dynamics and that Ca2+ stabilizes the synaptic 
ribbon. GCAP2 could mediate these Ca2+-dependent effects by chelating Ca2+ at the 
synaptic ribbon. Chelating Ca2+ by GCAP2 which has been recruited to RIBEYE via 
a NAD(H)-dependent mechanism at the synaptic ribbon thus would result in a 
reduction in the number of synaptic ribbons. The hypothesis that GCAP2 is important 
for the stability of synaptic ribbons is supported by our finding that viral 
overexpression of GCAP2 in photoreceptors reduces the number of synaptic ribbons; 
GCAP2 overexpression in the synapse works similar on ribbon dynamics as chelating 
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Ca2+. Both procedures lead to a preferential disassembly of synaptic ribbons although 
the size of the responses is bigger in the virus-induced disassembly of synaptic 
ribbons. This is probably due to intracellular overexpression of the Ca2+ chelating 
protein which can be expected to induce a stronger effect than the indirect 
manipulation of intracellular Ca2+ through the chelation of extracellular Ca2+.  
 
 
Figure 37. Schematic, simplified working model of RIBEYE-GCAP2 interaction in the photoreceptor ribbon 
synapse. The synaptic ribbon is anchored at the active zone of photoreceptor ribbon synapses and located close to 
L-type, voltage-gated presynaptic Ca2+-channels (Cav1.4). RIBEYE, a major component of synaptic ribbons, 
forms the scaffold of the synaptic ribbon via RIBEYE-RIBEYE interactions. RIBEYE consists of a unique A-
domain with mainly structural functions and a B-domain that specifically binds NAD(H). Based on currently 
available data (Schmitz et al., 2000; Alpadi et al., 2008), the B-domain of RIBEYE probably points to the 
cytoplasmic face of synaptic ribbons. GCAP2 binds to RIBEYE(B) in a NAD(H)-dependent manner. We suggest 
that binding of NAD(H) to RIBEYE recruits GCAP2 to synaptic ribbons. The dynamic, NAD(H)-dependent  
nature of RIBEYE/GCAP2 interaction could explain why most, but not all, synaptic ribbons co-localize with 
GCAP2 (Fig. 26). 
 
Photoreceptor terminals also contain guanylate cyclases (Liu et al., 1994, Cooper et 
al., 1995; Duda et al., 2002; Venkataraman et al., 2003) that might be targeted by 
GCAP2. The regulation of intracellular cGMP levels is important for various aspects 
of structural and functional plasticity of photoreceptor terminals (Spiwoks Becker et 
al., 2004; Zhang et al., 2005). cGMP-gated Ca2+-channels have been reported in 
photoreceptor synapses which could be targeted by GCAP2-regulated cGMP levels to 
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adjust synaptic transmission (Rieke and Schwartz, 1994, Savchenko et al., 1997; 
Müller et al., 2003). Which synaptic mechanisms are targeted by RIBEYE-GCAP2 
interaction, the characterization of GCAP2 effector proteins, how GCAP2- effector 
interaction is affected by intracellular Ca2+ concentrations and how the recruitment of 
NADH to RIBEYE is regulated remains to be elucidated by future analyses. 
The selective association of GCAP2 with photoreceptor synaptic ribbons but 
not with bipolar cell synaptic ribbons can contribute to known physiological 
differences between different types of retinal ribbon synapses (e.g. Heidelberger et 
al., 1994; Thoreson et al. 2004; Sheng et al., 2007). We suggest that the disturbance 
of synaptic transmission in GCAP2 knockout mice (Pennesi et al. 2003) as measured 
by reduced b-waves in ERG analyses is due to a defect in synaptic transmission at 
photoreceptor ribbon synapses. 
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